scholarly article | Q13442814 |
P50 | author | Kathleen B. Fedan | Q124638500 |
P2093 | author name string | John R. Odencrantz | |
John L. Hankinson | |||
P2860 | cites work | Comparison of spirometric reference values for Caucasian and African American blue-collar workers | Q26340406 |
Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population | Q26341853 | ||
Standardization of Spirometry, 1994 Update. American Thoracic Society | Q29547574 | ||
Analysis of spirometric data from a national sample of healthy 6- to 24-year-olds (NHANES II). | Q36439017 | ||
Spirometric prediction equations for Hispanic children and adults in New Mexico | Q41260489 | ||
Normal spirometric values in healthy Hispanic Americans | Q46131251 | ||
Pulmonary function between 6 and 18 years of age. | Q46340194 | ||
Blue-collar normative spirometric values for Caucasian and African-American men and women aged 18 to 65. | Q46906913 | ||
Pulmonary function growth velocity in children 6 to 18 years of age. | Q50605463 | ||
Ventilatory functions of normal children and young adults—Mexican-American, white, and black. I. Spirometry | Q52774126 | ||
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society | Q68060128 | ||
Performance evaluation of contemporary spirometers | Q68698424 | ||
Standardization of spirometry--1987 update. Statement of the American Thoracic Society | Q69438135 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lung | Q7886 |
respiratory disease | Q3286546 | ||
age factor | Q64705711 | ||
P5008 | on focus list of Wikimedia project | Wikimedia–NIOSH collaboration | Q104416361 |
P304 | page(s) | 179-187 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
P859 | sponsor | NIOSH Respiratory Health Division | Q123344459 |
P1476 | title | Spirometric reference values from a sample of the general U.S. population | |
P478 | volume | 159 |
Q23916693 | "Sarcoid like" granulomatous pulmonary disease in World Trade Center disaster responders |
Q97419442 | 2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages |
Q47715717 | A 30-year mortality and respiratory morbidity study of refractory ceramic fiber workers |
Q39431780 | A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life |
Q90159571 | A Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene® MIST) in Subjects with Intermittent or Mild-to-Moderate Persistent Asthma |
Q47639018 | A Genome-wide Association Study in Hispanics/Latinos Identifies Novel Signals for Lung Function. The Hispanic Community Health Study/Study of Latinos. |
Q36259851 | A Low Peripheral Blood CD4/CD8 Ratio Is Associated with Pulmonary Emphysema in HIV. |
Q36945570 | A Multidimensional Risk Score to Predict All-Cause Hospitalization in Community-Dwelling Older Individuals With Obstructive Lung Disease |
Q35904059 | A Novel Method for Quantifying the Inhaled Dose of Air Pollutants Based on Heart Rate, Breathing Rate and Forced Vital Capacity |
Q39565310 | A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria |
Q41009614 | A Randomized Controlled Trial of the Effect of Broccoli Sprouts on Antioxidant Gene Expression and Airway Inflammation in Asthmatics |
Q23915116 | A case-control study of airways obstruction among construction workers |
Q40305430 | A clinical tool to calculate post-transplant survival using pre-transplant clinical characteristics in adults with cystic fibrosis |
Q35694483 | A comparative study of COPD burden between urban vs rural communities in northern Thailand |
Q39818504 | A comparison of change point models with application to longitudinal lung function measurements in children with cystic fibrosis. |
Q24723908 | A comparison of work-exacerbated asthma cases from clinical and epidemiological settings |
Q47350235 | A critical evaluation of the anabolic response after bolus or continuous feeding in COPD and healthy older adults |
Q34244383 | A cross-sectional study of the association between ventilation of gas stoves and chronic respiratory illness in U.S. children enrolled in NHANESIII. |
Q38857955 | A four-dimensional computed tomography comparison of healthy and asthmatic human lungs |
Q90301407 | A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity |
Q28393089 | A genome-wide association study of chronic obstructive pulmonary disease in Hispanics |
Q36709708 | A genome-wide association study on African-ancestry populations for asthma |
Q33793755 | A large cohort study concerning age-dependent impacts of anthropometric variables on spirometric parameters in nonsmoking healthy adults |
Q28385862 | A long term study of pulmonary function among US refractory ceramic fibre workers |
Q36288899 | A mathematical reason for FEV1/FVC dependence on age |
Q51715157 | A method to determine in vivo, specific airway compliance, in humans. |
Q30993697 | A methodology for exploring biomarker--phenotype associations: application to flow cytometry data and systemic sclerosis clinical manifestations |
Q34681751 | A multiphase non-linear mixed effects model: An application to spirometry after lung transplantation |
Q47742406 | A new measure to assess asthma's effect on quality of life from the patient's perspective |
Q41224787 | A new spirometry-based algorithm to predict occupational pulmonary restrictive impairment. |
Q30425302 | A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis genetic modifier studies. |
Q28258072 | A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome) |
Q39112638 | A physiologically based model for spirometric reference equations in adults. |
Q41006493 | A pilot feeding study for adults with asthma: The healthy eating better breathing trial |
Q23922055 | A pilot respiratory health assessment of nail technicians: symptoms, lung function, and airway inflammation |
Q38836303 | A primary care-based asthma program improves recognition and treatment of persistent asthma in inner-city children compared to routine care |
Q34162881 | A prospective assessment of mortality in chronic spinal cord injury. |
Q24719059 | A prospective cohort study among new Chinese coal miners: the early pattern of lung function change |
Q46543859 | A prospective multicenter study of factors associated with hospital admission among adults with acute asthma |
Q36477485 | A prospective multicenter study of written action plans among emergency department patients with acute asthma |
Q23920607 | A prospective study of lung function among boilermaker construction workers exposed to combustion particulates |
Q38613709 | A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product |
Q34045280 | A randomized study of contingency management and spirometric lung age for motivating smoking cessation among injection drug users |
Q38811264 | A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease |
Q36040501 | A retrospective study of two populations to test a simple rule for spirometry |
Q37313126 | A review of the role of FEV1 in the COPD paradigm |
Q35819760 | A survey of early health effects of the Eyjafjallajokull 2010 eruption in Iceland: a population-based study |
Q34042726 | A systematic review of the association between pleural plaques and changes in lung function |
Q30536662 | A systematic review with attempted network meta-analysis of asthma therapy recommended for five to eighteen year olds in GINA steps three and four |
Q34060246 | ADAM19 and HTR4 variants and pulmonary function: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study |
Q46877836 | ADAM33 is not associated with asthma in Puerto Rican or Mexican populations |
Q33278280 | ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study |
Q34176597 | ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos |
Q28387051 | APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema |
Q97422148 | ARTP statement on pulmonary function testing 2020 |
Q35533910 | Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD. |
Q36377080 | Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia |
Q35465419 | Absolute leukocyte telomere length in HIV-infected and uninfected individuals: evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease |
Q77789752 | Accelerated lung function decline in an aluminium manufacturing industry cohort exposed to PM2.5: an application of the parametric g-formula |
Q23913169 | Accelerated spirometric decline in New York City firefighters with alpha 1-antitrypsin deficiency |
Q39419824 | Accuracy and Quality of Spirometry in Primary Care Offices |
Q92407140 | Accuracy of Vitalograph lung monitor as a screening test for COPD in primary care |
Q58104707 | Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study |
Q42376027 | Accuracy of maximal expiratory flow-volume curve curvilinearity and fractional exhaled nitric oxide for detection of children with atopic asthma |
Q64971577 | Achievements, Problems, and Future Direction of the Quality Control Program for Special Periodic Health Examination Agencies in Republic of Korea. |
Q37073820 | Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. |
Q35137917 | Active rehabilitation during extracorporeal membrane oxygenation as a bridge to lung transplantation. |
Q39458622 | Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease |
Q37185643 | Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children |
Q100526126 | Acute respiratory muscle unloading improves time-to-exhaustion during moderate- and heavy-intensity cycling in obese adolescent males |
Q36913410 | Adherence to airway clearance therapy in pediatric cystic fibrosis: Socioeconomic factors and respiratory outcomes |
Q30415316 | Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts. |
Q36094376 | Adiposity influences airway wall thickness and the asthma phenotype of HIV-associated obstructive lung disease: a cross-sectional study |
Q33836146 | Admissions to Canadian hospitals for acute asthma: a prospective, multicentre study |
Q34308364 | Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study |
Q36338286 | Admixture-matched case-control study: a practical approach for genetic association studies in admixed populations |
Q46095991 | Adrenergic responsiveness: FEV1 and symptom differences in Whites and African Americans with mild asthma |
Q40351810 | Advantages of Video Questionnaire in Estimating Asthma Prevalence and Risk Factors for School Children: Findings From an Asthma Survey in American Indian Youth |
Q46129659 | Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS. |
Q79151784 | Age does not affect airway pH and ammonia as determined by exhaled breath measurements |
Q33557226 | Age- and size-related reference ranges: a case study of spirometry through childhood and adulthood |
Q58770396 | Age-dependent effects of thoracic and capillary blood volume distribution on pulmonary artery pressure and lung diffusing capacity |
Q52984301 | Age-related differences in image quality of prospectively ECG-triggered axial and helical scans for coronary CT angiography. |
Q55147840 | Aging-related trajectories of lung function in the general population-The Doetinchem Cohort Study. |
Q23912608 | Agricultural work exposures and pulmonary function among hired farm workers in California (the MICASA study) |
Q28387179 | Air pollution and percent emphysema identified by computed tomography in the Multi-Ethnic study of Atherosclerosis |
Q24815322 | Air pollution-associated changes in lung function among asthmatic children in Detroit |
Q37125516 | Airflow Limitation and Endothelial Dysfunction. Unrelated and Independent Predictors of Atherosclerosis |
Q57392464 | Airflow Limitation is Underrecognized in Well-Functioning Older People |
Q92311690 | Airflow Obstruction and Cardio-metabolic Comorbidities |
Q40045883 | Airflow Obstruction and Use of Solid Fuels for Cooking or Heating: BOLD Results. |
Q44364948 | Airflow limitation in Brazilian Caucasians: FEV1/FEV6 vs. FEV1/FVC |
Q64135007 | Airflow obstruction among ever-employed U.S. adults aged 18-79 years by industry and occupation: NHANES 2007-2008 to 2011-2012 |
Q23912727 | Airflow obstruction attributable to work in industry and occupation among U.S. race/ethnic groups: a study of NHANES III data |
Q37177357 | Airflow obstruction in young adults in Canada |
Q36055202 | Airway Obstruction Worsens in Young Adults with Asthma Who Become Obese |
Q35713729 | Airway TGF-β1 and oxidant stress in children with severe asthma: association with airflow limitation |
Q37292431 | Airway factor XIII associates with type 2 inflammation and airway obstruction in asthmatic patients |
Q30440105 | Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress |
Q48892688 | Airway hyperreactivity is frequent in non-asthmatic children with sickle cell disease. |
Q46105094 | Airway narrowing and bronchodilation to deep inspiration in bronchial segments from subjects with and without reported asthma. |
Q23917607 | Airway obstruction among Latino poultry processing workers in North Carolina |
Q33670720 | Airway wall area derived from 3-dimensional computed tomography analysis differs among lung lobes in male smokers |
Q34347617 | Airway wall thickness is increased in COPD patients with bronchodilator responsiveness |
Q44679201 | Airways obstruction among older construction and trade workers at Department of Energy nuclear sites |
Q91816533 | Albuminuria, Lung Function Decline, and Risk of Incident Chronic Obstructive Pulmonary Disease. The NHLBI Pooled Cohorts Study |
Q41035295 | Algorithm for Predicting Disease Likelihood From a Submaximal Exercise Test |
Q40792981 | Allergen-induced early and late asthmatic responses to inhaled seasonal and perennial allergens. |
Q38963457 | Allergic disease associations with regional and localized estimates of air pollution. |
Q46761506 | Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR. |
Q57909754 | Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups |
Q36937623 | Alterations in whole-body arginine metabolism in chronic obstructive pulmonary disease |
Q45990922 | Altered pulmonary function in children with asthma associated with highway traffic near residence. |
Q38611353 | Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study |
Q41440710 | AltitudeOmics: impaired pulmonary gas exchange efficiency and blunted ventilatory acclimatization in humans with patent foramen ovale after 16 days at 5,260 m. |
Q48858650 | Alveolar and exhaled NO in relation to asthma characteristics--effects of correction for axial diffusion. |
Q36741283 | Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma |
Q47709878 | Alveolar-capillary membrane conductance is the best pulmonary function correlate of exercise ventilation efficiency in heart failure patients |
Q80488845 | Alveolar-membrane diffusing capacity improves in the morbidly obese after bariatric surgery |
Q34415939 | Alveolar-membrane diffusing capacity limits performance in Boston marathon qualifiers |
Q28389819 | Ambient Ammonia Exposures in an Agricultural Community and Pediatric Asthma Morbidity |
Q43364251 | Ambient particulate matter may affect lung function of motorcycle taxi drivers in Bangkok |
Q28649520 | Ambient polycyclic aromatic hydrocarbons and pulmonary function in children |
Q58556279 | An Open-Label Study Evaluating the Performance of the Dose Indicator in a Metered Dose Inhaler Delivering Glycopyrrolate and Formoterol Fumarate in Patients with Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease |
Q24645999 | An african-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity |
Q48390718 | An index of daily step count and systemic inflammation predicts clinical outcomes in chronic obstructive pulmonary disease |
Q33921664 | An integrated model of environmental factors in adult asthma lung function and disease severity: a cross-sectional study |
Q35534747 | An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications |
Q37522916 | An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice |
Q41673144 | Analysis of ADRB2 (Arg16Gly) Gene Variant with Susceptibility, Pharmacogenetic Response and Disease Severity in South Indian Asthmatics |
Q40839333 | Analysis of Risk Factors for Abnormal Pulmonary Function in Pediatric Cancer Survivors. |
Q90697901 | Analysis of high predicted pulmonary function: possibility of overestimation in small elderly examinees |
Q21091065 | Analysis of the lung microbiome in the "healthy" smoker and in COPD |
Q34213861 | Annual average ambient particulate matter exposure estimates, measured home particulate matter, and hair nicotine are associated with respiratory outcomes in adults with asthma |
Q33829417 | Antenatal steroid exposure and pulmonary outcomes in adolescents born with very low birth weight |
Q47107604 | Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study |
Q47103711 | Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis |
Q41588110 | Antibiotic treatment of signs and symptoms of pulmonary exacerbations: a comparison by care site |
Q46947430 | Antioxidants, oxidative stress, and pulmonary function in individuals diagnosed with asthma or COPD. |
Q31108509 | Applicability of the Global Lung Initiative 2012 Reference Values for Spirometry for Longitudinal Data of Elderly Women |
Q35767487 | Application of a new spirometric reference equation and its impact on the staging of Korean chronic obstructive pulmonary disease patients |
Q34241514 | Application of dyadic data analysis in pediatric psychology: cystic fibrosis health-related quality of life and anxiety in child-caregiver dyads |
Q34427151 | Application of the asthma phenotype algorithm from the Severe Asthma Research Program to an urban population |
Q35915157 | Application of the new GOLD COPD staging system to a US primary care cohort, with comparison to physician and patient impressions of severity |
Q38767772 | Are physical measures related to patient-centred outcomes in ARDS survivors? |
Q100464838 | Area under the expiratory flow-volume curve: predicted values by artificial neural networks |
Q36917907 | Armodafinil for sarcoidosis-associated fatigue: a double-blind, placebo-controlled, crossover trial |
Q23912028 | Arterial stiffness, oxidative stress, and smoke exposure in wildland firefighters |
Q37647201 | Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects |
Q91710247 | Assessing small airway disease in GLI versus NHANES III based spirometry using area under the expiratory flow-volume curve |
Q34914012 | Assessing the value of disease management: impact of 2 disease management strategies in an underserved asthma population |
Q36752360 | Assessment of regional ventilation and deformation using 4D-CT imaging for healthy human lungs during tidal breathing. |
Q39068190 | Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study. |
Q40146631 | Association Between CD4(+), Viral Load, and Pulmonary Function in HIV. |
Q39308217 | Association Between Insomnia and Asthma Burden in the Severe Asthma Research Program (SARP) III. |
Q28391820 | Association Between Pulmonary Function and Nonalcoholic Fatty Liver Disease in the NHANES III Study |
Q36873560 | Association between 24-hour urinary cadmium and pulmonary function among community-exposed men: the VA Normative Aging Study |
Q57475807 | Association between Deepwater Horizon oil spill response and cleanup work experiences and lung function |
Q28389082 | Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study |
Q35050053 | Association between lung function and disability in African-Americans |
Q34056068 | Association between obstructive lung disease and markers of HIV infection in a high-risk cohort |
Q28386034 | Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene |
Q50918838 | Association between peripheral airway function and neutrophilic inflammation in asthma. |
Q48448349 | Association between physical activity and major depressive disorder among current or former smokers with pulmonary disease. |
Q35562870 | Association between the introduction of a new cystic fibrosis inhaled antibiotic class and change in prevalence of patients receiving multiple inhaled antibiotic classes |
Q41619118 | Association between vitamin D and respiratory outcomes in Canadian adolescents and adults |
Q36403167 | Association of Acroosteolysis With Enhanced Osteoclastogenesis and Higher Blood Levels of Vascular Endothelial Growth Factor in Systemic Sclerosis |
Q36906238 | Association of C-reactive protein with reduced forced vital capacity in a nonsmoking U.S. population with metabolic syndrome and diabetes |
Q24812745 | Association of FEV1 in asthmatic children with personal and microenvironmental exposure to airborne particulate matter |
Q89970843 | Association of Nonobstructive Chronic Bronchitis With Respiratory Health Outcomes in Adults |
Q41675310 | Association of Serum Lipids and Obstructive Lung Disease in Hispanic/Latino Adults of Diverse Backgrounds |
Q92748184 | Association of Undifferentiated Dyspnea in Late Life With Cardiovascular and Noncardiovascular Dysfunction: A Cross-sectional Analysis From the ARIC Study |
Q90281193 | Association of birthplace and occupational exposures with chronic bronchitis in US Hispanics/Latinos, 2008-2011 |
Q40525694 | Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis |
Q35509719 | Association of chronic cough and pulmonary function with 6-minute walk test performance in HIV infection |
Q33650371 | Association of circulating adhesion molecules with lung function. The CARDIA study |
Q35007883 | Association of elevated plasminogen activator inhibitor 1 levels with diminished lung function in patients with asthma |
Q23923288 | Association of expired nitric oxide with occupational particulate exposure |
Q57812237 | Association of heavy metals with measures of pulmonary function in children and youth: Results from the National Health and Nutrition Examination Survey (NHANES) |
Q38698488 | Association of prenatal and early childhood stress with reduced lung function in 7-year-olds |
Q28397397 | Association of pulmonary function with adiposity and metabolic abnormalities in urban minority adolescents |
Q33483203 | Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis |
Q44566807 | Association of systemic inflammation, adiposity, and metabolic dysregulation with asthma burden among Hispanic adults |
Q55058645 | Association of transforming growth factor-Beta 1 promoter variant -509 c/t with bronchial asthma in South Indian population. |
Q36650440 | Associations among lung function, arterial elasticity, and circulating endothelial and inflammation markers: the multiethnic study of atherosclerosis |
Q37139237 | Associations between adherence, depressive symptoms and health-related quality of life in young adults with cystic fibrosis. |
Q96298223 | Associations between individual perceptions of PM2.5 pollution and pulmonary function in Chinese middle-aged and elderly residents |
Q51709822 | Associations between laryngeal and cough dysfunction in motor neuron disease with bulbar involvement. |
Q40138096 | Associations between treatment, scoliosis, pulmonary function, and physical performance in long-term survivors of sarcoma |
Q50101724 | Associations between vitamin D and pulmonary function in chronic spinal cord injury. |
Q23916859 | Associations of World Trade Center exposures with pulmonary and cardiometabolic outcomes among children seeking care for health concerns |
Q36741293 | Associations of dairy intake with CT lung density and lung function |
Q36075673 | Associations of obesity and asthma with functional exercise capacity in urban minority adolescents |
Q64110284 | Associations of variants In the hexokinase 1 and interleukin 18 receptor regions with oxyhemoglobin saturation during sleep |
Q34510954 | Associations with chest illness and mortality in chronic spinal cord injury |
Q57090608 | Asthma Control in a Random Sample of New Zealand Adolescent Asthmatics |
Q47669536 | Asthma Screening in Pediatric Sickle Cell Disease: A Clinic-Based Program Using Questionnaires and Spirometry |
Q38604609 | Asthma and Chronic Obstructive Pulmonary Disease Overlap: The Effect of Definitions on Measures of Burden |
Q92367561 | Asthma and academic performance in urban children |
Q23912020 | Asthma and asthma severity among African American adults in the Jackson Heart Study |
Q48418826 | Asthma and lung function in a birth cohort at 6-7 years of age in southern Brazil. |
Q28394032 | Asthma and lung structure on computed tomography: the Multi-Ethnic Study of Atherosclerosis Lung Study |
Q36525457 | Asthma and odors: the role of risk perception in asthma exacerbation |
Q36292443 | Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study |
Q36279538 | Asthma in Hispanics |
Q55437810 | Asthma in children of Caribbean descent living in the inner-city: comparing Puerto Rican and Afro-Caribbean children. |
Q33396229 | Asthma is inversely associated with Helicobacter pylori status in an urban population |
Q30423167 | Asthma outcomes: pulmonary physiology |
Q51853060 | Asthma severity categorization using a claims-based algorithm or pulmonary function testing. |
Q36408615 | Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients |
Q24814484 | Asthma symptoms in Hispanic children and daily ambient exposures to toxic and criteria air pollutants |
Q36381315 | Asthma, airflow limitation and mortality risk in the general population |
Q48270610 | Asthma, chronic obstructive pulmonary disease, and mortality in the U.S. population |
Q23912396 | Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate |
Q40472019 | Asthma-related lung function, sleep quality, and sleep duration in urban children. |
Q34132007 | Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial |
Q39796070 | Atopy, but not obesity is associated with asthma severity among children with persistent asthma |
Q45951302 | Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children. |
Q37615212 | Automated CT scan scores of bronchiectasis and air trapping in cystic fibrosis |
Q36004783 | Automated quantitative 3D analysis of aorta size, morphology, and mural calcification distributions |
Q89063670 | Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial |
Q36116891 | Azithromycin for the Treatment of Obliterative Bronchiolitis after Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis |
Q44462802 | Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis |
Q43460035 | Bariatric surgery: severity, level of control, and time required for preoperative asthma control |
Q37125524 | Barriers to Understanding the Epidemiology of Noncommunicable Lung Disease in Sub-Saharan Africa |
Q32944421 | Bayesian quantile impairment threshold benchmark dose estimation for continuous endpoints |
Q37470190 | Being overweight increases susceptibility to indoor pollutants among urban children with asthma |
Q37122519 | Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis |
Q34485014 | Best lung function equations for the very elderly selected by survival analysis |
Q46129563 | Beta 2-adrenergic receptor polymorphisms: pharmacogenetic response to bronchodilator among African American asthmatics |
Q43243148 | Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate |
Q34191240 | Bilateral functional thoracic outlet syndrome in a collegiate football player. |
Q35923222 | Biomarkers of pulmonary hypertension in patients with scleroderma: a case-control study |
Q36218552 | Biomarkers of rheumatoid arthritis-associated interstitial lung disease |
Q28386721 | Bisphenol A exposure is associated with decreased lung function |
Q47666470 | Blood Leukocyte Concentrations, FEV1 Decline, and Airflow Limitation. A 15-Year Longitudinal Study of World Trade Center-exposed Firefighters |
Q30933471 | Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials |
Q35633624 | Body composition and functional limitation in COPD. |
Q38837301 | Body composition and lung function in children with cystic fibrosis and meconium ileus |
Q36626788 | Body composition and lung function in cystic fibrosis and their association with adiposity and normal-weight obesity |
Q30413619 | Body composition and pulmonary function in cystic fibrosis |
Q36915488 | Body mass and glucocorticoid response in asthma. |
Q33813557 | Body mass index change in gastrointestinal cancer and chronic obstructive pulmonary disease is associated with Dedicator of Cytokinesis 1. |
Q37610950 | Both pulmonary and extra-pulmonary factors predict the development of disability in chronic obstructive pulmonary disease |
Q40435806 | Breastfeeding associated with higher lung function in African American youths with asthma. |
Q36539226 | Breath acidification in adolescent runners exposed to atmospheric pollution: a prospective, repeated measures observational study |
Q40313882 | Breathing retraining for African-American adolescents with asthma: a pilot study of a school-based randomized controlled trial |
Q89366395 | Breathing valve resistance alters physiological responses during a graded exercise test |
Q41108261 | Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. |
Q46604045 | Bringing Lung Function Prediction Equations to Diverse Populations |
Q28065051 | Bronchial reactivity and lung function after World Trade Center exposure |
Q45728403 | Bronchial responsiveness in patients with restrictive spirometry |
Q39477117 | Bronchoarterial ratio in never-smokers adults: Implications for bronchial dilation definition. |
Q30515766 | Bronchoconstriction triggered by breathing hot humid air in patients with asthma: role of cholinergic reflex. |
Q35789357 | Bronchodilation response to deep inspirations in asthma is dependent on airway distensibility and air trapping |
Q77790844 | Bronchodilator response predicts longitudinal improvement in small airway function in World Trade Center dust exposed community members |
Q93184784 | Bronchodilators for hyperinflation in COPD associated with biomass smoke: clinical trial |
Q49148594 | C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. |
Q98619726 | CASTER: Cross-Sectional Asthma STEroid Response Measurement |
Q46068802 | CD14 tobacco gene-environment interaction modifies asthma severity and immunoglobulin E levels in Latinos with asthma |
Q36176931 | CHRNA3/5, IREB2, and ADCY2 are associated with severe chronic obstructive pulmonary disease in Poland |
Q36901699 | COPD as a systemic disease: impact on physical functional limitations |
Q35968539 | COPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study |
Q28391708 | COPD in never smokers: results from the population-based burden of obstructive lung disease study |
Q36837701 | COPD prevalence in a random population survey: a matter of definition. |
Q40812499 | CT-derived Biomechanical Metrics Improve Agreement Between Spirometry and Emphysema. |
Q35906558 | Can a normal peak expiratory flow exclude severe chronic obstructive pulmonary disease? |
Q36604236 | Can spirometric norms be set using pre- or post- bronchodilator test results in older people? |
Q43065415 | Canadian Thoracic Society Pulmonary Function Standards Committee |
Q35703771 | Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study. |
Q48062667 | Cardiac, ventilatory, and metabolic adjustments in chronic obstructive pulmonary disease patients during the performance of Glittre activities of daily living test |
Q51695887 | Cardiopulmonary correlates of cognition in systemic lupus erythematosus. |
Q36709815 | Cardiopulmonary function in individuals with HIV infection in the antiretroviral therapy era. |
Q33720328 | Cardiorespiratory fitness, adiposity, and incident asthma in adults. |
Q36836417 | Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS) |
Q35743713 | Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life |
Q23912728 | Case definitions for chronic obstructive pulmonary disease |
Q23921738 | Case-control study of lung function in World Trade Center health registry area residents and workers |
Q36487800 | Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study |
Q23916707 | Change in prevalence of restrictive lung impairment in the U.S. population and associated risk factors: the National Health and Nutrition Examination Survey (NHANES) 1988-1994 and 2007-2010 |
Q37340271 | Changes in estimated right ventricular systolic pressure predict mortality and pulmonary hypertension in a cohort of scleroderma patients. |
Q41199736 | Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling |
Q51694795 | Changes in lung function during an extreme mountain ultramarathon. |
Q43637729 | Changes in lung function in children with sickle cell disease. |
Q33762863 | Changes in pediatric health-related quality of life in cystic fibrosis after IV antibiotic treatment for pulmonary exacerbations |
Q23910813 | Changes in prevalence of chronic obstructive pulmonary disease and asthma in the US population and associated risk factors |
Q85655722 | Changes in tongue pressure, pulmonary function, and salivary flow in patients with amyotrophic lateral sclerosis |
Q89805834 | Characterising a Weight Loss Intervention in Obese Asthmatic Children |
Q40353004 | Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults. |
Q40864330 | Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study |
Q23915008 | Characteristics of a residential and working community with diverse exposure to World Trade Center dust, gas, and fumes |
Q99549349 | Characterization of Persistent Uncontrolled Asthma Symptoms in Community Members Exposed to World Trade Center Dust and Fumes |
Q39761994 | Characterization of pulmonary function in Duchenne Muscular Dystrophy |
Q31110246 | Characterizing Lung Disease in Cystic Fibrosis with Magnetic Resonance Imaging and Airway Physiology. |
Q52654142 | Chest CT Scan Findings in World Trade Center Workers. |
Q34541959 | Chest computed tomography findings in HIV-infected individuals in the era of antiretroviral therapy |
Q34984718 | Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction |
Q36818364 | Children and young adults with CF in the USA have better lung function compared with the UK. |
Q34542566 | China suboptimal health cohort study: rationale, design and baseline characteristics. |
Q30278529 | Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial |
Q30353005 | Choline supplementation alters some amino acid concentrations with no change in homocysteine in children with cystic fibrosis and pancreatic insufficiency. |
Q35914605 | Chronic Bronchitis Is Associated With Worse Symptoms and Quality of Life Than Chronic Airflow Obstruction |
Q35906553 | Chronic airflow obstruction and markers of systemic inflammation: results from the BOLD study in Iceland |
Q23910818 | Chronic and acute exposures to the World Trade Center disaster and lower respiratory symptoms: area residents and workers |
Q36446491 | Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk |
Q89219136 | Chronic obstructive pulmonary disease |
Q36482639 | Chronic obstructive pulmonary disease in Hispanics |
Q36225551 | Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function? |
Q28658590 | Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis |
Q37598879 | Chronic obstructive pulmonary disease: an update on diagnosis and management issues in older adults |
Q93162394 | Chronic pesticide mixture exposure including paraquat and respiratory outcomes among Colombian farmers |
Q34205461 | Cigarette smoking and pulmonary function in adult survivors of childhood cancer exposed to pulmonary-toxic therapy: results from the St. Jude lifetime cohort study |
Q37343777 | Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. |
Q33898390 | Cigarette smoking, cadmium exposure, and zinc intake on obstructive lung disorder |
Q56480036 | Circulating fibrocytes as biomarkers of impaired lung function in adults with sickle cell disease |
Q90324721 | Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort |
Q53560949 | Circulating neutrophil CD14 expression and the inverse association of ambient particulate matter on lung function in asthmatic children. |
Q38043495 | Citation classics: Top 50 cited articles in 'respiratory system'. |
Q33821761 | Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis |
Q23914035 | Classification of voluntary cough airflow patterns for prediction of abnormal spirometry |
Q47678958 | Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters |
Q34632321 | Clinical Decision Support Systems (CDSS) for preventive management of COPD patients |
Q47910794 | Clinical Impact of Intrapulmonary Vascular Dilatation in Candidates for Liver Transplant |
Q30277842 | Clinical Implications of Having Reduced Mid Forced Expiratory Flow Rates (FEF25-75), Independently of FEV1, in Adult Patients with Asthma |
Q37141699 | Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function |
Q36516546 | Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD) |
Q39683513 | Clinical and functional differences between early-onset and late-onset adult asthma: a population-based Tasmanian Longitudinal Health Study |
Q35781301 | Clinical and genetic correlates of exercise performance in young children with cystic fibrosis |
Q30504247 | Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study |
Q30278434 | Clinical correlates of lung ventilation defects in asthmatic children. |
Q64059270 | Clinical evaluation of sarcoidosis in community members with World Trade Center dust exposure |
Q34480471 | Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis |
Q44272126 | Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis. |
Q34612842 | Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD) |
Q33670620 | Clinical risk factors for portopulmonary hypertension |
Q37679780 | Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis |
Q45883669 | Clinical trial readiness in non-ambulatory boys and men with duchenne muscular dystrophy: MDA-DMD network follow-up |
Q33942782 | Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis. |
Q33684320 | Clinical use of tobramycin inhalation solution (TOBI®) shows sustained improvement in FEV1 in cystic fibrosis |
Q34159164 | Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. |
Q28392443 | Cluster Analysis in Patients with GOLD 1 Chronic Obstructive Pulmonary Disease |
Q38771840 | Combined Impact of Smoking and Early Life Exposures on Adult Lung Function Trajectories. |
Q58726621 | Combined respiratory training in an individual with C9orf72 amyotrophic lateral sclerosis |
Q38805229 | Combined use of fractional exhaled nitric oxide and bronchodilator response in predicting future loss of asthma control among children with atopic asthma |
Q23915623 | Comorbid trends in World Trade Center cough syndrome and probable posttraumatic stress disorder in firefighters |
Q47122143 | Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study. |
Q50584866 | Comparative lung function performance of stroke survivors and age-matched and sex-matched controls. |
Q36968540 | Comparing the harmful effects of nontuberculous mycobacteria and Gram negative bacteria on lung function in patients with cystic fibrosis |
Q45301370 | Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure |
Q34360230 | Comparison between reference values for FVC, FEV1, and FEV1/FVC ratio in White adults in Brazil and those suggested by the Global Lung Function Initiative 2012. |
Q37177429 | Comparison of Canadian versus American emergency department visits for acute asthma |
Q38663490 | Comparison of FEV1 reference equations for evaluating a cystic fibrosis therapeutic intervention |
Q51905766 | Comparison of Indian reference equations for spirometry interpretation. |
Q36162521 | Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting. |
Q64097419 | Comparison of hypothesis- and data-driven asthma phenotypes in NHANES 2007-2012: the importance of comprehensive data availability |
Q40381994 | Comparison of sitting and supine forced vital capacity in collagen VI-related dystrophy and laminin α2-related dystrophy. |
Q34345197 | Comparison of spatially matched airways reveals thinner airway walls in COPD. The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study and the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) |
Q47988401 | Comparison of spirometric reference values. |
Q30586386 | Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. |
Q35906564 | Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study |
Q51642089 | Comparison of the ATS versus EU Mini Wright peak flow meter in normal volunteers. |
Q55279440 | Comparison of the fixed ratio and the Z-score of FEV1/FVC in the elderly population: a long-term mortality analysis from the Third National Health and Nutritional Examination Survey. |
Q47141566 | Comparison of the six-minute walk test with a cycle-based cardiopulmonary exercise test in people following curative intent treatment for non-small cell lung cancer |
Q90655371 | Comparison of two methods of determining lung de-recruitment, using the forced oscillation technique |
Q37172645 | Complementary and alternative asthma treatments and their association with asthma control: a population-based study. |
Q89609508 | Comprehensive metabolic flux analysis to explain skeletal muscle weakness in COPD |
Q36446778 | Concave pattern of a maximal expiratory flow-volume curve: a sign of airflow limitation in adult bronchial asthma |
Q36584709 | Concentrated ambient fine particles and not ozone induce a systemic interleukin-6 response in humans |
Q34502750 | Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation |
Q37396797 | Considerations for managing chronic obstructive pulmonary disease in the elderly |
Q40560942 | Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline |
Q35570918 | Construct validity and minimal important difference of 6-minute walk distance in survivors of acute respiratory failure |
Q89936687 | Contraceptive use among women with cystic fibrosis: A pilot study linking reproductive health questions to the Cystic Fibrosis Foundation National Patient Registry |
Q33337944 | Contribution of smoking and air pollution exposure in urban areas to social differences in respiratory health |
Q33621353 | Contributors to diffusion impairment in HIV-infected persons |
Q47911760 | Controlled invasive mechanical ventilation strategies in obese patients undergoing surgery |
Q34379760 | Controlled-frequency breath swimming improves swimming performance and running economy. |
Q34149521 | Controversies in the use of spirometry for early recognition and diagnosis of chronic obstructive pulmonary disease in cigarette smokers |
Q36050806 | Conundrums in childhood asthma severity, control, and health care use: Puerto Rico versus Rhode Island |
Q92477164 | Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis |
Q28391717 | Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients |
Q38197155 | Correlation of pulmonary function abnormalities with dose volume histograms in children treated with lung irradiation. |
Q37699490 | Correlation of regional emphysema and lung cancer: a lung tissue research consortium-based study. |
Q37261891 | Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD |
Q37730578 | Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model |
Q37225484 | Cost-effectiveness and healthcare budget impact in Italy of inhaled corticosteroids and bronchodilators for severe and very severe COPD patients. |
Q61448301 | Cost-effectiveness of physical activity in the management of COPD patients in the UK |
Q104288266 | Could routine race-adjustment of spirometers exacerbate racial disparities in COVID-19 recovery? |
Q33868585 | Critical comparisons of the clinical performance of oxygen-conserving devices |
Q33575488 | Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV. |
Q47797124 | Cross-cultural adaptation and assessment of reproducibility of the Duke Activity Status Index for COPD patients in Brazil. |
Q35024732 | Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever-smokers |
Q46495412 | Cross-sectional and longitudinal spirometry in children and adolescents: interpretative strategies |
Q37356441 | Cross-sectional associations of pulmonary function with systemic inflammation and oxidative stress in individuals with chronic spinal cord injury |
Q24683901 | Cured meat consumption, lung function, and chronic obstructive pulmonary disease among United States adults |
Q89766335 | Current Bronchodilator Responsiveness Criteria Underestimate Asthma in Older Adults |
Q36367904 | Current Smoking Status Is Associated With Lower Quantitative CT Measures of Emphysema and Gas Trapping |
Q58737001 | Cystic Fibrosis Mortality in Childhood. Data from European Cystic Fibrosis Society Patient Registry |
Q38886356 | Cystic Fibrosis Pulmonary Exacerbations Attributable to Respiratory Syncytial Virus and Influenza: A Population-Based Study. |
Q64109746 | Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information |
Q44100059 | Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection |
Q89585608 | Cystic fibrosis patients at risk for disease progression marked by decline in FEV1% predicted: development of the cystic fibrosis risk of disease progression score |
Q60921478 | Daily Objective Physical Activity and Sedentary Time in Adults with COPD Using Spirometry Data from Canadian Measures Health Survey |
Q33758278 | Daily serum creatinine monitoring promotes earlier detection of acute kidney injury in children and adolescents with cystic fibrosis. |
Q34673119 | Daily step count predicts acute exacerbations in a US cohort with COPD. |
Q36617736 | Daily step counts in a US cohort with COPD. |
Q23915841 | Decline in lung function and mortality: implications for medical monitoring |
Q45352196 | Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin |
Q47192174 | Decreased Lung Function and All-cause Mortality in HIV-Infected Individuals |
Q33540140 | Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: data from NHANES III. |
Q90224395 | Decreased serum TRAIL is associated with increased mortality in smokers with comorbid emphysema and coronary artery disease |
Q33364816 | Deficits in bone mineral content in children and adolescents with cystic fibrosis are related to height deficits |
Q42648400 | Defining Airflow Obstruction |
Q36143545 | Defining obstructive ventilatory defect in 2015. |
Q37418902 | Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene |
Q35528347 | Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study |
Q37151413 | Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids |
Q34155594 | Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function |
Q36471493 | Depression, Asthma, and Bronchodilator Response in a Nationwide Study of US Adults |
Q33836302 | Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint. |
Q42717982 | Design and powering of cystic fibrosis clinical trials using rate of FEV(1) decline as an efficacy endpoint |
Q35969522 | Detecting chronic obstructive pulmonary disease using peak flow rate: cross sectional survey |
Q38993344 | Detection of smoothly distributed spatial outliers, with applications to identifying the distribution of parenchymal hyperinflation following an airway challenge in asthmatics |
Q58802555 | Determinants and outcomes of change in physical activity in COPD |
Q36734220 | Determinants of 6-minute walk distance in patients with idiopathic pulmonary fibrosis undergoing lung transplant evaluation |
Q64119322 | Determinants of airflow limitation in Danish adults - findings from the Health2006 cohort |
Q36225916 | Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency |
Q35851133 | Determinants of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), and FEV1/FVC in chronic spinal cord injury |
Q34309078 | Development and implementation of treadmill exercise testing protocols in COPD |
Q36667785 | Development and psychometric properties of the Pulmonary-specific Quality-of-Life Scale in lung transplant patients |
Q33697687 | Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study |
Q36627282 | Development of a spirometry T-score in the general population |
Q26822946 | Development of biomarkers to optimize pediatric patient management: what makes children different? |
Q48002469 | Development of reference equations for spirometry in Japanese children aged 6-18 years |
Q37392242 | Developmental adaptation: where we go from here |
Q33602207 | Diabetes as a determinant of mortality in cystic fibrosis |
Q23912018 | Diabetes, impaired glucose tolerance, and metabolic biomarkers in individuals with normal glucose tolerance are inversely associated with lung function: The Jackson Heart Study |
Q34628631 | Diagnosis and early detection of COPD using spirometry |
Q36789935 | Diagnosis of COPD and clinical course in patients with unrecognized airflow limitation |
Q36108519 | Diagnosis of airway obstruction in the elderly: contribution of the SARA study |
Q36037447 | Diagnostic accuracy of FEV1/forced vital capacity ratio z scores in asthmatic patients |
Q37419986 | Diagnostic yield of nasal scrape biopsies in primary ciliary dyskinesia: a multicenter experience. |
Q49982245 | Diet Pattern and Respiratory Morbidity in the Atherosclerosis Risk in Communities Study. |
Q43960733 | Diet-induced weight loss in obese children with asthma: a randomized controlled trial |
Q45217805 | Dietary intake of soy genistein is associated with lung function in patients with asthma |
Q36741284 | Difference in airflow obstruction between Hispanic and non-Hispanic White female smokers. |
Q40692298 | Differences in Health-Related Quality of Life Between New Mexican Hispanic and Non-Hispanic White Smokers. |
Q47558264 | Differences in Respiratory Symptoms and Lung Structure Between Hispanic and Non-Hispanic White Smokers: A Comparative Study |
Q40760295 | Differences in spirometry values between U.S. children 6-11 years and adolescents 12-19 years with current asthma, 2007-2010. |
Q37417522 | Differential assessment and management of asthma vs chronic obstructive pulmonary disease. |
Q28818183 | Differential methylation between ethnic sub-groups reflects the effect of genetic ancestry and environmental exposures |
Q54367456 | Diffusion capacity of carbon monoxide (DLCO) pre- and post-exercise in children in health and disease. |
Q34093112 | Direct assessment of lung function in COPD using CT densitometric measures |
Q34342750 | Disability and recovery of independent function in obstructive lung disease: the cardiovascular health study. |
Q35933274 | Discordance in spirometric interpretations based on korean and non-korean reference equations |
Q93011938 | Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality |
Q51970737 | Disease-specific reference equations for lung function in patients with cystic fibrosis. |
Q28586320 | Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers |
Q64279662 | Distinctive lung function trajectories from age 10 to 26 years in men and women and associated early life risk factors - a birth cohort study |
Q36569151 | Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study |
Q90105582 | Do Baseline Asthma and Allergic Sensitization Characteristics Predict Responsiveness to Mouse Allergen Reduction? |
Q36373826 | Do current OELs for silica protect from obstructive lung impairment? A critical review of epidemiological data |
Q35184982 | Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers? |
Q38237766 | Do genetic polymorphisms alter patient response to inhaled bronchodilators? |
Q47819002 | Do individuals with asthma experience airway hyper-responsiveness after exposure to nitrogen dioxide? |
Q57174309 | Does Low FEV1 in Addition to Fixed Ratio and/or Lower Limit of Normal of FEV1/FVC Improve Prediction of Mortality in COPD? The NHANES-III-linked-mortality Cohort |
Q28584595 | Does Mental Health Status Influence Susceptibility to the Physiologic Effects of Air Pollution? A Population Based Study of Canadian Children |
Q91832030 | Does Posterior Scoliosis Correction Improve Respiratory Function in Adolescent Idiopathic Scoliosis? A Systematic Review and Meta-analysis |
Q44980467 | Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis? |
Q36737490 | Does harboring hostility hurt? Associations between hostility and pulmonary function in the Coronary Artery Risk Development in (Young) Adults (CARDIA) study |
Q37322256 | Does higher body mass index contribute to worse asthma control in an urban population? |
Q46646565 | Does low vitamin D amplify the association of COPD with total and cardiovascular disease mortality? |
Q35677934 | Does respiratory health contribute to the effects of long-term air pollution exposure on cardiovascular mortality? |
Q36036488 | Does wearing clothing made of a synthetic "cooling" fabric improve indoor cycle exercise endurance in trained athletes? |
Q41643962 | Domestic exposure to endotoxin and respiratory morbidity in former smokers with COPD. |
Q33643220 | Dose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over study |
Q36582335 | Dose-response relationships between mouse allergen exposure and asthma morbidity among urban children and adolescents |
Q34143925 | Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients |
Q31165485 | Dynamics of Disease Progression and Gastrostomy Tube Placement in Children and Adolescents with Cystic Fibrosis: Application of Joint Models for Longitudinal and Time-to-Event Data |
Q93340306 | Dyspnea on exertion provokes unpleasantness and negative emotions in women with obesity |
Q52730720 | Dysregulated invertebrate tropomyosin-dectin-1 interaction confers susceptibility to allergic diseases. |
Q88208458 | Early Detection of Rapid Cystic Fibrosis Disease Progression Tailored to Point of Care: A Proof-of-Principle Study |
Q51762850 | Early Midlife Pulmonary Function and Dementia Risk. |
Q23916401 | Early changes in clinical, functional, and laboratory biomarkers in workers at risk of indium lung disease |
Q33688123 | Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection. |
Q34705576 | Early detection and management of COPD. What you can do to reduce the impact of this disabling disease |
Q45364383 | Early-Life Pseudomonas aeruginosa Infection in Cystic Fibrosis and Lung Disease Progression |
Q30504483 | Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study |
Q28389143 | Eastern Carolina Asthma Prevention Program (ECAPP): An Environmental Intervention Study Among Rural and Underserved Children with Asthma in Eastern North Carolina |
Q41166063 | Echocardiographic Pulmonary Artery Systolic Pressure in the Coronary Artery Risk Development in Young Adults (CARDIA) Study: Associations With Race and Metabolic Dysregulation. |
Q59335055 | Effect of Abdominal Binding on Diaphragmatic Neuromuscular Efficiency, Exertional Breathlessness, and Exercise Endurance in Chronic Obstructive Pulmonary Disease |
Q91822411 | Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial |
Q40658560 | Effect of Continuous Positive Airway Pressure on Airway Reactivity in Asthma. A Randomized, Sham-controlled Clinical Trial |
Q28388912 | Effect of Emphysema Severity on the Apnea-Hypopnea Index in Smokers with Obstructive Sleep Apnea |
Q40494559 | Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction. |
Q47962322 | Effect of Hydroxyurea Therapy on Pulmonary Function in Children with Sickle Cell Anemia |
Q41434170 | Effect of Megestrol Acetate and Testosterone on Body Composition and Hormonal Responses in COPD Cachexia |
Q24624885 | Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation |
Q30371144 | Effect of a dietary intervention on growth and energy expenditure in children with cystic fibrosis. |
Q37224490 | Effect of change of reference standard to NHANES III on interpretation of spirometric 'abnormality' |
Q37581210 | Effect of changing from the National Health and Nutritional Examination Survey III spirometry reference range to that of the Global Lung Initiative 2012 at Gold Coast Hospital and Health Service |
Q64267111 | Effect of changing reference equations for spirometry interpretation in Thai people |
Q36664397 | Effect of emphysema on CT scan measures of airway dimensions in smokers |
Q36099476 | Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function |
Q61456232 | Effect of ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis patients with G551D-CFTR |
Q47136819 | Effect of oral glycine on the clinical, spirometric and inflammatory status in subjects with cystic fibrosis: a pilot randomized trial |
Q43184645 | Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial |
Q39578759 | Effect of residential proximity to major roadways on cystic fibrosis exacerbations |
Q43605384 | Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis |
Q34085781 | Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study |
Q35565168 | Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation |
Q33924795 | Effect of urbanisation on asthma, allergy and airways inflammation in a developing country setting |
Q38652401 | Effect on health-related quality of life of ongoing feedback during a 12-month maintenance walking programme in patients with COPD: a randomized controlled trial |
Q51101328 | Effectiveness of essential amino acid supplementation in stimulating whole body net protein anabolism is comparable between COPD patients and healthy older adults. |
Q88446017 | Effectiveness of ivacaftor in cystic fibrosis patients with non-G551D gating mutations |
Q38643100 | Effects of Chest Physical Therapy in Patients with Non-Tuberculous Mycobacteria. |
Q48344147 | Effects of Pulmonary Rehabilitation on Activity Levels in Patients With Chronic Obstructive Pulmonary Disease |
Q41752364 | Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials. |
Q40105561 | Effects of air pollution on lung function and symptoms of asthma, rhinitis and eczema in primary school children |
Q37186992 | Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease |
Q58483999 | Effects of an aging pulmonary system on expiratory flow limitation and dyspnoea during exercise in healthy women |
Q33491393 | Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity |
Q44786641 | Effects of changing reference values and definition of the normal range on interpretation of spirometry. |
Q51651940 | Effects of exercise intensity compared to albuterol in individuals with cystic fibrosis. |
Q64891223 | Effects of interleukin-6 receptor blockade on allergen-induced airway responses in mild asthmatics. |
Q35190104 | Effects of obesity and bariatric surgery on airway hyperresponsiveness, asthma control, and inflammation |
Q51683432 | Effects of particulate air pollution on nasal and lung function development among Greek children: a 19-year cohort study. |
Q30569184 | Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study. |
Q47408523 | Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma - a randomized controlled trial. |
Q35119914 | Effects of woodsmoke exposure on airway inflammation in rural Guatemalan women |
Q90173311 | Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS |
Q40449015 | Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies. |
Q36945312 | Efficacy and safety of Technosphere inhaled insulin compared with Technosphere powder placebo in insulin-naive type 2 diabetes suboptimally controlled with oral agents |
Q36003938 | Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial |
Q36036894 | Efficacy and safety of once-daily inhaled umeclidinium/vilanterol in Asian patients with COPD: results from a randomized, placebo-controlled study |
Q94503677 | Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD |
Q48293345 | Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trial |
Q42363355 | Efficacy of Idebenone to Preserve Respiratory Function above Clinically Meaningful Thresholds for Forced Vital Capacity (FVC) in Patients with Duchenne Muscular Dystrophy |
Q33428499 | Efficacy of esomeprazole for treatment of poorly controlled asthma |
Q34669498 | Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial |
Q46498379 | Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease |
Q35215922 | Efficient screening for COPD using three steps: a cross-sectional study in Mexico City |
Q64955865 | Eight Weeks of Inspiratory Muscle Training Improves Pulmonary Function in Disabled Swimmers-A Randomized Trial. |
Q36253358 | Electrocardiographic differences between COPD patients evaluated for lung transplantation with and without pulmonary hypertension |
Q34075676 | Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction |
Q36539136 | Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007-2010. |
Q23909921 | Elevated peripheral eosinophils are associated with new-onset and persistent wheeze and airflow obstruction in World Trade Center-exposed individuals |
Q41659595 | Elevation of one hour plasma glucose during oral glucose tolerance testing. |
Q36652471 | Emergency Hospital Care for Exacerbation of COPD: Is Inhaled Maintenance Therapy Modified? |
Q33574429 | Emergency department visits for acute asthma by adults who ran out of their inhaled medications |
Q40218877 | Emphysema and soluble CD14 are associated with pulmonary nodules in HIV-infected patients: implications for lung cancer screening |
Q33791622 | Emphysema, airflow limitation, and early age-related macular degeneration |
Q51650894 | Endurance exercise performance in acute hypoxia is influenced by expiratory flow limitation. |
Q36609294 | Environmental allergies and respiratory morbidities in cystic fibrosis |
Q91501033 | Environmental correlates of chronic obstructive pulmonary disease in 96 779 participants from the UK Biobank: a cross-sectional, observational study |
Q24817169 | Environmental tobacco smoke exposure and pulmonary function among adults in NHANES III: impact on the general population and adults with current asthma |
Q37448511 | Eosinophil and T cell markers predict functional decline in COPD patients |
Q57037336 | Epidemiology and Risk Factors of Asthma-COPD Overlap in Low- and Middle-Income Countries |
Q34982469 | Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia |
Q28383674 | Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene |
Q40953204 | Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study |
Q37206455 | Establishing normal reference values in quantitative computed tomography of emphysema |
Q90204767 | Estimated time-varying exposures to air emissions from animal feeding operations and childhood asthma |
Q37029989 | Estimates of restrictive ventilatory defect in the mining industry. Considerations for epidemiological investigations: a cross-sectional study |
Q51100222 | Estimating endurance shuttle walk test speed using the six-minute walk test in people with chronic obstructive pulmonary disease. |
Q89716330 | Estimating minute ventilation and air pollution inhaled dose using heart rate, breath frequency, age, sex and forced vital capacity: a pooled-data analysis |
Q23922840 | Estimating the U.S. prevalence of chronic obstructive pulmonary disease using pre- and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007-2010 |
Q92267933 | Eteplirsen Treatment Attenuates Respiratory Decline in Ambulatory and Non-Ambulatory Patients with Duchenne Muscular Dystrophy |
Q41730032 | Ethnic differences in pulmonary function in healthy nonsmoking Asian-Americans and European-Americans |
Q35878541 | Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials |
Q35187401 | Ethnic variability in persistent asthma after in utero tobacco exposure |
Q45229718 | Ethnic- and sex-free formulae for detection of airway obstruction |
Q34702650 | Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma |
Q35855230 | Ethnicity-specific gene-gene interaction between IL-13 and IL-4Ralpha among African Americans with asthma |
Q37551087 | Evaluating Physical Outcomes in Acute Respiratory Distress Syndrome Survivors: Validity, Responsiveness, and Minimal Important Difference of 4-Meter Gait Speed Test |
Q92313149 | Evaluating the extremely elderly at a pulmonary function clinic for the diagnosis of respiratory disease: frequency and technical quality of spirometry |
Q36364163 | Evaluation of Community Action Against Asthma: a community health worker intervention to improve children's asthma-related health by reducing household environmental triggers for asthma |
Q92095032 | Evaluation of a five-year predicted survival model for cystic fibrosis in later time periods |
Q38055204 | Evaluation of bedoradrine sulfate (MN-221), a novel, highly selective beta2-adrenergic receptor agonist for the treatment of asthma via intravenous infusion |
Q44514395 | Evaluation of daily home spirometry for school children with asthma: new insights |
Q51718168 | Evaluation of respiratory symptoms and respiratory protection behavior among poultry workers in small farming operations. |
Q37349152 | Evaluation of structure-function relationships in asthma using multidetector CT and hyperpolarized He-3 MRI. |
Q39451107 | Evaluation of the Global Lung Initiative 2012 Reference Values for Spirometry in African Children. |
Q35562641 | Evaluation of the global lung function initiative 2012 reference values for spirometry in a Swedish population sample |
Q37459822 | Evaluation of unexplained dyspnea in a young athletic male with pectus excavatum |
Q35454043 | Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma |
Q47555997 | Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study. |
Q44868942 | Examining the association between lung functioning and cognitive performance in African American adults |
Q23918141 | Excessive longitudinal FEV1 decline and risks to future health: a case-control study |
Q64097175 | Exercise Capacity in Unilateral Diaphragm Paralysis: The Effect of Obesity |
Q64325157 | Exercise Stroke Volume in Adult Cystic Fibrosis: A Comparison of Acetylene Pulmonary Uptake and Oxygen Pulse |
Q47949032 | Exercise hyperventilation, dyspnea sensation, and ergoreflex activation in lone atrial fibrillation |
Q57791300 | Exercise testing in patients with cystic fibrosis-importance of ventilatory parameters |
Q34287607 | Exercise tolerance testing in a prospective cohort of adolescents with chronic fatigue syndrome and recovered controls following infectious mononucleosis |
Q35434875 | Exercise training for asbestos-related and other dust-related respiratory diseases: a randomised controlled trial |
Q51503284 | Exercise-associated Excessive Dynamic Airway Collapse in Military Personnel. |
Q34666476 | Exhaled NO among inner-city children in New York City |
Q89537663 | Exhaled Nitric Oxide in Wheezy Infants Predicts Persistent Atopic Asthma and Exacerbations at School Age |
Q36770672 | Exhaled breath condensate adenosine tracks lung function changes in cystic fibrosis |
Q37407192 | Exhaled breath condensate detects baseline reductions in chloride and increases in response to albuterol in cystic fibrosis patients |
Q30371124 | Exhaled breath condensate pH does not discriminate asymptomatic gastroesophageal reflux or the response to lansoprazole treatment in children with poorly controlled asthma. |
Q39943337 | Exhaled nitric oxide as a predictor of exacerbation in children with moderate-to-severe asthma: a prospective, 5-month study |
Q23918612 | Exhaled nitric oxide measurement in workers in a microwave popcorn production plant |
Q46174569 | Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study |
Q36968835 | Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12. |
Q36480384 | Experimental evidence of age-related adaptive changes in human acinar airways. |
Q36637768 | Expiratory Time Constant and Sleep Apnea Severity in the Overlap Syndrome |
Q53145189 | Expiratory and inspiratory forced vital capacity and one-second forced volume in asymptomatic never-smokers in Norway. |
Q35623972 | Expiratory flow limitation relates to symptoms during COPD exacerbations requiring hospital admission. |
Q45892678 | Exposure assessment and associated lung deposition calculations for vehicular exhaust in four metropolitan cities of Pakistan. |
Q24632644 | Exposure to asbestos-containing vermiculite ore and respiratory symptoms among individuals who were children while the mine was active in Libby, Montana |
Q47550249 | Exposure to oil spill chemicals and lung function in Deepwater Horizon disaster response workers |
Q36727777 | Exposure to traffic pollution, acute inflammation and autonomic response in a panel of car commuters |
Q37449124 | Exposure to traffic: lung function and health status in adults with asthma |
Q23910219 | Exposure, probable PTSD and lower respiratory illness among World Trade Center rescue, recovery and clean-up workers |
Q23912029 | Exposures and cross-shift lung function declines in wildland firefighters |
Q23910470 | Eye and respiratory symptoms in poultry processing workers exposed to chlorine by-products |
Q33640507 | FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices |
Q41515322 | FEV(6) as screening tool in spirometric diagnosis of obstructive airway disease. |
Q40082261 | FEV1 and FVC and systemic inflammation in a spinal cord injury cohort |
Q33863052 | FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure |
Q58689755 | FEV1/FEV6: A Reliable, Easy-to-Use, and Cheaper Alternative to FEV1/FVC in Diagnosing Airway Obstruction in Indian Population |
Q89581137 | FVC variability in patients with IPF and role of 6-min walk test to predict further change |
Q28388780 | Factors associated with abnormal spirometry among HIV-infected individuals |
Q36538147 | Factors associated with health-related quality of life in chronic spinal cord injury |
Q40321250 | Factors associated with misdiagnosis of COPD in primary care |
Q34372132 | Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis |
Q34388432 | Factors predicting inhaled corticosteroid responsiveness in African American patients with asthma |
Q35041495 | Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD |
Q33744911 | Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation |
Q30496365 | Familial aggregation of FEF(25-75) and FEF(25-75)/FVC in families with severe, early onset COPD. |
Q35410963 | Family history is a risk factor for COPD |
Q51915065 | Farming and the prevalence of non-reversible airways obstruction: results from a population-based study. |
Q59628656 | Feasibility and acceptability of using bronchial hyperresponsiveness to manage asthma in primary care: a pilot study |
Q54957662 | Feasibility of high-intensity training in asthma. |
Q36225974 | Feasible and simple exclusion criteria for pulmonary reference populations |
Q30436056 | Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide |
Q34538152 | Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis |
Q47924133 | Fibrinogen, COPD and mortality in a nationally representative U.S. cohort |
Q35822156 | Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts |
Q38763676 | Fibrosing myopathy in systemic sclerosis associates with higher mortality |
Q58993817 | First Report of FVC and FEV1 Reference Values for Beninese Children Aged 11–16 Years |
Q36839311 | Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns |
Q34172077 | Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses |
Q45942214 | Flexible semiparametric joint modeling: an application to estimate individual lung function decline and risk of pulmonary exacerbations in cystic fibrosis. |
Q35482098 | Florida Red Tide Toxins (Brevetoxins) and Longitudinal Respiratory Effects in Asthmatics |
Q40122431 | Fluticasone Furoate, Vilanterol and Lung Function Decline in Patients with Moderate COPD and Heightened Cardiovascular Risk. |
Q40744414 | Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial. |
Q23923897 | Follow-up study of respiratory health of newly-hired female cotton textile workers |
Q74140219 | Forced vital capacity in two large outpatient populations with chronic spinal cord injury |
Q34233774 | Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection |
Q51506239 | Four SNPs and Systemic Level of FOXP3 in Smokers and Patients with Chronic Obstructive Pulmonary Disease. |
Q36266907 | Fractional exhaled nitric oxide and forced expiratory flow between 25% and 75% of vital capacity in children with controlled asthma |
Q89885592 | Fractional exhaled nitric oxide and forced expiratory volume in 1 second/forced vital capacity have predictive value of asthma exacerbation in Korean school children |
Q37248523 | Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome: analysis of the National Health and Nutrition Examination Survey, 2007-2012 |
Q33300819 | Framingham Heart Study genome-wide association: results for pulmonary function measures |
Q36871425 | Frequency of circulating topoisomerase-I-specific CD4 T cells predicts presence and progression of interstitial lung disease in scleroderma |
Q38698618 | Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort |
Q53375637 | Functional capacity in children and young adults with sickle cell disease undergoing evaluation for cardiopulmonary disease. |
Q34543581 | Functional exercise capacity and health-related quality of life in people with asbestos related pleural disease: an observational study |
Q38556142 | Functional imaging of the lungs with gas agents. |
Q33829662 | Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis |
Q53609943 | Functional lung rejuvenation in obese patients after bariatric surgery. |
Q37341795 | Further exploration of the links between occupational exposure and chronic obstructive pulmonary disease |
Q37673443 | GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease |
Q60045113 | GLI 2012 equations define few spirometric anomalies in the general population: the PneumoLaus study |
Q28587875 | GOLD criteria overestimate airflow limitation in one-third of cases in the general Finnish population |
Q33905430 | GSNO reductase and beta2-adrenergic receptor gene-gene interaction: bronchodilator responsiveness to albuterol |
Q37125501 | Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities |
Q39416031 | Galloping Hooves in Africa: Horse, Zebra, or Wildebeest? |
Q35936008 | Gaps in using bronchodilators, inhaled corticosteroids and influenza vaccine among 23 high- and low-income sites |
Q28393574 | Gas stove use and respiratory health among adults with asthma in NHANES III |
Q45847233 | Gastro-oesophageal reflux and respiratory symptoms in Busselton adults: the effects of bodyweight and sleep apnoea. |
Q36988274 | Gender differences of airway dimensions in anatomically matched sites on CT in smokers |
Q34512258 | Gender-related differences in severe, early-onset chronic obstructive pulmonary disease |
Q90597958 | Gene-Environment Interaction between the IL1RN Variants and Childhood Environmental Tobacco Smoke Exposure in Asthma Risk |
Q34050109 | Gene-environment interactions influence airways function in laboratory animal workers |
Q36976272 | Gene-metabolite expression in blood can discriminate allergen-induced isolated early from dual asthmatic responses |
Q46075277 | Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics |
Q36438022 | Genetic ancestry and its association with asthma exacerbations among African American subjects with asthma |
Q28385877 | Genetic ancestry and the relationship of cigarette smoking to lung function and per cent emphysema in four race/ethnic groups: a cross-sectional study |
Q34071088 | Genetic ancestry in lung-function predictions |
Q37400642 | Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma |
Q28728158 | Genetic ancestry-smoking interactions and lung function in African Americans: a cohort study |
Q36842031 | Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. |
Q91908143 | Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations |
Q24604623 | Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease |
Q34037986 | Genetic variants of TSLP and asthma in an admixed urban population |
Q36079234 | Genetic variation in antioxidant enzymes and lung function |
Q41510380 | Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis. |
Q35549587 | Genetic variation of the alpha subunit of the epithelial Na+ channel influences exhaled Na+ in healthy humans. |
Q38846284 | Genetics and Genomics of Longitudinal Lung Function Patterns in Individuals with Asthma |
Q30427183 | Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. |
Q28943477 | Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2. |
Q36108378 | Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis |
Q30420166 | Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction |
Q37102310 | Genome-wide association study identifies TH1 pathway genes associated with lung function in asthmatic patients |
Q34425888 | Genome-wide interrogation of longitudinal FEV1 in children with asthma |
Q36225605 | Genome-wide linkage analysis of pulmonary function in families of children with asthma in Costa Rica |
Q34521964 | Genomewide linkage analysis of quantitative spirometric phenotypes in severe early-onset chronic obstructive pulmonary disease |
Q38979934 | Global differences in lung function by region (PURE): an international, community-based prospective study |
Q55318534 | Global lung function initiative 2012 reference values for spirometry in Asian Americans. |
Q85178153 | Glycemic control influences lung membrane diffusion and oxygen saturation in exercise-trained subjects with type 1 diabetes: alveolar-capillary membrane conductance in type 1 diabetes |
Q30580973 | Goodness-of-Fits of the Spirometric Reference Values for Koreans and USA Caucasians to Spirometry Data from Residents of a Region within Chungbuk Province |
Q58545823 | Greater Odds for Angina in Uranium Miners than Non-uranium Miners in New Mexico |
Q37141459 | Guideline-recommended fractional exhaled nitric oxide is a poor predictor of health-care use among inner-city children and adolescents receiving usual asthma care |
Q40440036 | HIV Infection Is Independently Associated with Increased CT Scan Lung Density |
Q47562441 | HIV Infection, Pulmonary Tuberculosis, and COPD in Rural Uganda: A Cross-Sectional Study. |
Q40480304 | HIV Suppression Restores the Lung Mucosal CD4+ T-Cell Viral Immune Response and Resolves CD8+ T-Cell Alveolitis in Patients at Risk for HIV-Associated Chronic Obstructive Pulmonary Disease. |
Q33898001 | HIV and COPD: impact of risk behaviors and diseases on quality of life. |
Q64095361 | HIV infection is an independent risk factor for decreased 6-minute walk test distance |
Q37378469 | HIV infection is associated with diffusing capacity impairment in women |
Q37354530 | HIV infection is associated with reduced pulmonary diffusing capacity |
Q47678075 | Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition. |
Q55283746 | Having concomitant asthma phenotypes is common and independently relates to poor lung function in NHANES 2007-2012. |
Q45237469 | Health conditions among aging narcotics addicts: medical examination results |
Q23914170 | Health consequences of the September 11 World Trade Center attacks: a review |
Q60302471 | Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD |
Q46942243 | Heterogeneity of bronchoconstriction does not distinguish mild asthmatic subjects from healthy controls when supine |
Q89585463 | Heterogeneity of perception of symptoms in patients with asthma |
Q59330072 | Heterogeneous burden of lung disease in smokers with borderline airflow obstruction |
Q39795035 | High ambient temperature and risk of intestinal obstruction in cystic fibrosis. |
Q38733234 | High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: A prospective cohort study |
Q37081095 | High-volume resistance training session acutely diminishes respiratory muscle strength |
Q50524302 | Higher tobramycin concentration and vibrating mesh technology can shorten antibiotic treatment time in cystic fibrosis. |
Q46811475 | Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results |
Q35308565 | House dust mite-specific immunoglobulin E and longitudinal exhaled nitric oxide measurements in children with atopic asthma |
Q35825599 | How Common Is Airflow Limitation in Patients With Emphysema on CT Scan of the Chest? |
Q47655441 | Human airway branch variation and chronic obstructive pulmonary disease |
Q34041231 | Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. |
Q36050653 | Humoral immune factors and asthma among American Indian children: a case-control study |
Q37446202 | Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion |
Q37381453 | Hyperpolarized Helium-3 MRI of exercise-induced bronchoconstriction during challenge and therapy. |
Q35906548 | Hypertension, systemic inflammation and body weight in relation to lung function impairment-an epidemiological study |
Q47281901 | Hypoxic Pulmonary Vasoconstriction Does Not Explain All Regional Perfusion Redistribution in Asthma. |
Q57909745 | Identification of Chronic Obstructive Pulmonary Disease Axes That Predict All-Cause Mortality: The COPDGene Study |
Q37466106 | Identification of early interstitial lung disease in smokers from the COPDGene Study |
Q90695022 | Identifying Protein-metabolite Networks Associated with COPD Phenotypes |
Q34573422 | Identifying adults at risk of COPD who need confirmatory spirometry in primary care: Do symptom-based questions help? |
Q90571947 | Identifying potential causal effects of age at menarche: a Mendelian randomization phenome-wide association study |
Q37094687 | Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline |
Q48328751 | Imaging of lung ventilation and respiratory dynamics in a single ventilation cycle using hyperpolarized He-3 MRI. |
Q36064083 | Impact of Functional Endoscopic Sinus Surgery on the Pulmonary Function of Patients with Chronic Rhinosinusitis: A Prospective Study |
Q47643314 | Impact of HIV Infection on Alpha-1 Antitrypsin in the Lung |
Q47135831 | Impact of Physical Activity on Reporting of Childhood Asthma Symptoms. |
Q36226940 | Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis |
Q28744261 | Impact of air pollution on pulmonary function and respiratory symptoms in children. Longitudinal repeated-measures study |
Q39798721 | Impact of bronchodilator use on the prevalence of COPD in population-based samples |
Q35794475 | Impact of direct substitution of arm span length for current standing height in elderly COPD. |
Q41044100 | Impact of farm modernity on the prevalence of chronic obstructive pulmonary disease in dairy farmers |
Q98195478 | Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort |
Q33670611 | Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates |
Q64990848 | Impact of lung-function measures on cardiovascular disease events in older adults with metabolic syndrome and diabetes. |
Q44296679 | Impact of obesity on the severity and therapeutic responsiveness of acute episodes of asthma |
Q33637604 | Impact of pulmonary artery pressure on exercise function in severe COPD. |
Q57794653 | Impact of pulmonary emphysema on exercise capacity and its physiological determinants in chronic obstructive pulmonary disease |
Q37110224 | Impact of race on the severity of acute episodes of asthma and adrenergic responsiveness |
Q33727936 | Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort |
Q52333765 | Impact of social complexity on outcomes in cystic fibrosis after transfer to adult care. |
Q35536123 | Impaired lung function and serum leptin in men and women with normal body weight: a population based study |
Q79216206 | Impaired lung function is associated with obesity and metabolic syndrome in adults |
Q34781489 | Implications of population structure and ancestry on asthma genetic studies |
Q47861134 | Important non-disease-related determinants of exhaled nitric oxide levels in mild asthma - results from the Swedish GA(2) LEN study |
Q34146921 | Improved CT-based estimate of pulmonary gas trapping accounting for scanner and lung-volume variations in a multicenter asthmatic study |
Q42625764 | Improved biomass stove intervention in rural Mexico: impact on the respiratory health of women |
Q37171964 | Improved pulmonary and growth outcomes in cystic fibrosis by newborn screening |
Q94563709 | Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial |
Q47573122 | Improved spirometric detection of small airway narrowing: concavity in the expiratory flow-volume curve in people aged over 40 years. |
Q44775088 | Improved survival with an ambulatory model of non-invasive ventilation implementation in motor neuron disease. |
Q27908433 | Improvement in severe lower respiratory symptoms and small airway function in World Trade Center dust exposed community members |
Q53891956 | Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure. |
Q91875292 | Improving Detection of Rapid Cystic Fibrosis Disease Progression-Early Translation of a Predictive Algorithm Into a Point-of-Care Tool |
Q36860528 | Improving performance in the detection and management of cystic fibrosis-related diabetes in the Mountain West Cystic Fibrosis Consortium |
Q37365183 | In Vitro Tests for Aerosol Deposition. IV: Simulating Variations in Human Breath Profiles for Realistic DPI Testing |
Q57040971 | In patients with unilateral pleural effusion, restricted lung inflation is the principal predictor of increased dyspnoea |
Q28386616 | In utero and early childhood exposure to arsenic decreases lung function in children |
Q33769791 | In vivo and in vitro ivacaftor response in cystic fibrosis patients with residual CFTR function: N-of-1 studies |
Q37072981 | In-home air pollution is linked to respiratory morbidity in former smokers with chronic obstructive pulmonary disease |
Q33640782 | Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study |
Q53249129 | Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. |
Q57444903 | Increased Airway Wall Thickness is Associated with Adverse Longitudinal First-Second Forced Expiratory Volume Trajectories of Former World Trade Center workers |
Q40140048 | Increased Dead Space Ventilation Mediates Reduced Exercise Capacity in Systolic Heart Failure. |
Q36618438 | Increased matrix metalloproteinase (MMPs) levels do not predict disease severity or progression in emphysema |
Q77790241 | Increased pulmonary artery diameter is associated with reduced FEV1 in former World Trade Center workers |
Q23910814 | Increased respiratory disease mortality at a microwave popcorn production facility with worker risk of bronchiolitis obliterans |
Q34609920 | Increased risk of radiographic emphysema in HIV is associated with elevated soluble CD14 and nadir CD4. |
Q36615100 | Increased tricuspid regurgitant jet velocity by Doppler echocardiography in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study |
Q60306442 | Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week |
Q39993595 | Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma |
Q36104206 | Indicators of asthma control among students in a rural, school-based asthma management program |
Q37306244 | Individualized prediction of lung-function decline in chronic obstructive pulmonary disease. |
Q88758561 | Indoor black carbon and biomarkers of systemic inflammation and endothelial activation in COPD patients |
Q88159613 | Indoor black carbon of outdoor origin and oxidative stress biomarkers in patients with chronic obstructive pulmonary disease |
Q34241735 | Indoor pollutant exposure is associated with heightened respiratory symptoms in atopic compared to non-atopic individuals with COPD |
Q23918615 | Induced sputum evaluation in microwave popcorn production workers |
Q23922607 | Industry-wide medical surveillance of California flavor manufacturing workers: cross-sectional results |
Q60934016 | Inflammation and transcriptional responses of peripheral blood mononuclear cells in classic ataxia telangiectasia |
Q37305923 | Inflammatory markers and longitudinal lung function decline in the elderly |
Q36036012 | Inflammatory markers and mortality among US adults with obstructive lung function |
Q36148605 | Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects |
Q47898397 | Influence of Inhaled Amiloride on Lung Fluid Clearance in Response to Normobaric Hypoxia in Healthy Individuals |
Q28395068 | Influence of cardiorespiratory fitness on lung cancer mortality |
Q34324786 | Influence of distinct asthma phenotypes on lung function following weight loss in the obese |
Q39658127 | Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy |
Q55454926 | Influence of the Vibralung Acoustical Percussor on pulmonary function and sputum expectoration in individuals with cystic fibrosis. |
Q40505534 | Inhalation of tobramycin using simulated cystic fibrosis patient profiles |
Q45263529 | Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients |
Q35537366 | Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease |
Q24246224 | Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma |
Q43166401 | Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas |
Q24813022 | Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma |
Q57466140 | Inspiratory Lung Expansion in Patients with Interstitial Lung Disease: CT Histogram Analyses |
Q37601392 | Inspiratory flows and volumes in subjects with cystic fibrosis using a new dry powder inhaler device |
Q40786711 | Insulin resistance modifies the association between obesity and current asthma in adults |
Q36031080 | Insulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients |
Q34743505 | Insurance and quality of care for adults with acute asthma |
Q35868427 | Integrating Multiple Correlated Phenotypes for Genetic Association Analysis by Maximizing Heritability |
Q100317970 | Integrative genomic analysis in African American children with asthma finds three novel loci associated with lung function |
Q37334535 | Integrative omics approach identifies interleukin-16 as a biomarker of emphysema |
Q30278644 | Integrative pathway genomics of lung function and airflow obstruction |
Q45325242 | Interferon response to respiratory syncytial virus by bronchial epithelium from children with asthma is inversely correlated with pulmonary function |
Q29614971 | International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study |
Q37078765 | Interpretation of pediatric lung function: impact of ethnicity. |
Q51152587 | Interpretative consequences of adopting the Global Lungs 2012 reference equations for spirometry for children and adolescents. |
Q23912395 | Interpreting screening questionnaires: specific respiratory symptoms and their relationship to objective test results |
Q36889912 | Intersession variability in single-breath diffusing capacity in diabetics without overt lung disease. |
Q90024835 | Investigation of the Obesity Paradox in Chronic Obstructive Pulmonary Disease, According to Smoking Status, in the United States |
Q92997447 | Investigation of the Prevalence and Diagnosis of Chronic Obstructive Pulmonary Disease in a Group of Elderly Individuals Residing in an Island Area of Ningbo |
Q35091847 | Iron status is associated with asthma and lung function in US women |
Q35065959 | Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis |
Q33949352 | Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? |
Q35189528 | Is inflammatory chronic obstructive pulmonary disease a coronary heart disease risk equivalent? A longitudinal analysis of the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. |
Q36756529 | Is lung function associated with bone mineral density? Results from the Hertfordshire Cohort Study |
Q43920174 | Is spirometry properly used to diagnose COPD? Results from the BOLD study in Salzburg, Austria: a population-based analytical study. |
Q60412535 | Is the COPD Assessment Test sensitive for differentiating COPD patients from active smokers and nonsmokers without lung function impairment? A population-based study |
Q51457768 | Isolated diffusing capacity reduction is a common clinical presentation in deployed Iraq and Afghanistan veterans with deployment-related environmental exposures. |
Q27908430 | Isolated small airway reactivity during bronchoprovocation as a mechanism for respiratory symptoms in WTC dust-exposed community members |
Q92312623 | Isolating peripheral effects of endogenous opioids in modulating exertional breathlessness in people with moderate or severe COPD: a randomised controlled trial |
Q23910498 | Joint effects of smoking and sedentary lifestyle on lung function in African Americans: the Jackson Heart Study cohort |
Q55113707 | Joint hierarchical Gaussian process model with application to personalized prediction in medical monitoring. |
Q34333877 | Jointly modeling the relationship between longitudinal and survival data subject to left truncation with applications to cystic fibrosis |
Q37684557 | LINKING LUNG AIRWAY STRUCTURE TO PULMONARY FUNCTION VIA COMPOSITE BRIDGE REGRESSION. |
Q23924132 | Lack of respiratory improvement following remediation of a water-damaged office building |
Q34127482 | Lansoprazole for children with poorly controlled asthma: a randomized controlled trial |
Q40500350 | Larger FVC and FEV1 among Tibetans compared to Han born and raised at high altitude |
Q35106951 | Late-age onset systemic sclerosis. |
Q39332004 | Lean mass, not fat mass, is associated with lung function in male and female children with asthma. |
Q23912019 | Leptin is inversely associated with lung function in African Americans, independent of adiposity: The Jackson Heart Study |
Q23916084 | Lessons from the World Trade Center disaster: airway disease presenting as restrictive dysfunction |
Q34179764 | Lessons learned from a randomized trial of airway secretion clearance techniques in cystic fibrosis |
Q30434309 | Levels of nitric oxide oxidation products are increased in the epithelial lining fluid of children with persistent asthma |
Q50098943 | Libby Amphibole Disease: Pulmonary Function and CT Abnormalities in Vermiculite Miners. |
Q37168335 | Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study |
Q37723754 | Lifestyle Risk Factors for Weight Gain in Children with and without Asthma |
Q36383673 | Limited lung function: impact of reduced peak expiratory flow on health status, health-care utilization, and expected survival in older adults |
Q34921541 | Long term effects of cyclophosphamide treatment on lung function and survival in scleroderma patients with interstitial lung disease |
Q33435110 | Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study |
Q47247419 | Long-Term Pulmonary Function in Duchenne Muscular Dystrophy: Comparison of Eteplirsen-Treated Patients to Natural History. |
Q52647264 | Long-term changes in spirometry in occupational divers: a 10-25 year audit. |
Q44986369 | Long-term effects of pregnancy and motherhood on disease outcomes of women with cystic fibrosis |
Q37310075 | Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis. |
Q35262059 | Long-term exposure to traffic emissions and fine particulate matter and lung function decline in the Framingham heart study |
Q53139077 | Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study. |
Q39171713 | Long-term pulmonary complications in perinatally HIV-infected youth |
Q35021502 | Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study |
Q89009828 | Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study |
Q41590797 | Longitudinal analysis of endurance and respiratory function from a natural history study of Morquio A syndrome. |
Q37059572 | Longitudinal analysis of pulmonary function in adults with sickle cell disease |
Q45074613 | Longitudinal and Cross-sectional Analyses of Lung Function in Toluene Diisocyanate Production Workers |
Q33926448 | Longitudinal assessment of high versus low levels of fractional exhaled nitric oxide among children with asthma and atopy |
Q23913315 | Longitudinal assessment of spirometry in the World Trade Center medical monitoring program |
Q35042866 | Longitudinal association between medication adherence and lung health in people with cystic fibrosis. |
Q36662310 | Longitudinal association of body mass index with lung function: the CARDIA study. |
Q39113823 | Longitudinal associations of adiposity with adult lung function in the Childhood Determinants of Adult Health (CDAH) study |
Q42067438 | Longitudinal change in FEV1 and FVC in chronic spinal cord injury. |
Q53556429 | Longitudinal changes in lung function and somatic growth in children with sickle cell disease. |
Q37262682 | Longitudinal decline in lung volume in a population of children with sickle cell disease. |
Q23915947 | Longitudinal lung function declines among California flavoring manufacturing workers |
Q35021749 | Longitudinal lung function growth of Mexican children compared with international studies. |
Q23922627 | Longitudinal pulmonary function in newly hired, non-World Trade Center-exposed fire department City of New York firefighters: the first 5 years |
Q23918197 | Longitudinal spirometry among patients in a treatment program for community members with World Trade Center-related illness |
Q92993366 | Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers |
Q90543364 | Low FVC/TLC in Preserved Ratio Impaired Spirometry (PRISm) is associated with features of and progression to obstructive lung disease |
Q40809304 | Low prevalence of obstructive lung disease in a suburban population of Malaysia: A BOLD collaborative study. |
Q42971122 | Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population |
Q48122985 | Low-level environmental tobacco smoke exposure and inflammatory biomarkers in children with asthma |
Q34276838 | Lower Bronchodilator Responsiveness in Puerto Rican than in Mexican Subjects with Asthma |
Q28386606 | Lower limit of normal based spirometric abnormalities associated with radiographic abnormality in an elderly cohort at low risk for exposure |
Q36609344 | Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. |
Q48031387 | Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR. |
Q89527596 | Luminal Plugging on Chest CT Scan: Association With Lung Function, Quality of Life, and COPD Clinical Phenotypes |
Q23922622 | Lung Function Trajectories in World Trade Center-Exposed New York City Firefighters Over 13 Years: The Roles of Smoking and Smoking Cessation |
Q96229640 | Lung Function and Gene Expression of Pathogen Recognition Pathway Receptors: the Cardia Lung Study |
Q28388901 | Lung Function before and after a Large Chlorine Gas Release in Graniteville, South Carolina |
Q36243220 | Lung Function in Rural Guatemalan Women Before and After a Chimney Stove Intervention to Reduce Wood Smoke Exposure: Results From the Randomized Exposure Study of Pollution Indoors and Respiratory Effects and Chronic Respiratory Effects of Early Chi |
Q93375129 | Lung Function of Children at Three Sites of Varying Ambient Air Pollution Levels in Uganda: A Cross Sectional Comparative Study |
Q29248734 | Lung Function, Percent Emphysema, and QT Duration: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study |
Q37122572 | Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease |
Q28396803 | Lung function and metabolic syndrome: Findings of National Health and Nutrition Examination Survey 2007–2010 |
Q34777879 | Lung function and risk for heart failure among older adults: the Health ABC Study |
Q34449048 | Lung function decline from adolescence to young adulthood in cystic fibrosis |
Q90671580 | Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study |
Q34206825 | Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects |
Q28390521 | Lung function in adults following in utero and childhood exposure to arsenic in drinking water: preliminary findings |
Q39820641 | Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation |
Q28391439 | Lung function in asbestos-exposed workers, a systematic review and meta-analysis |
Q47576663 | Lung function in early adulthood and health in later life: a transgenerational cohort analysis |
Q47551771 | Lung function in oil spill response workers 1-3 years after the Deepwater Horizon disaster |
Q28384406 | Lung function in our aging population |
Q23922624 | Lung function in rescue workers at the World Trade Center after 7 years |
Q33804084 | Lung function in young adults predicts airflow obstruction 20 years later. |
Q100635470 | Lung function over the life course of paediatric and adult patients with cystic fibrosis from a large multi-centre registry |
Q81468567 | Lung function reference values in children and adolescents aged 6 to 18 years in Galicia |
Q24801297 | Lung function, asthma symptoms, and quality of life for children in public housing in Boston: a case-series analysis |
Q40556403 | Lung function, respiratory symptoms and venous thromboembolism risk: the Atherosclerosis Risk in Communities Study. |
Q36575194 | Lung inflammation biomarkers and lung function in children chronically exposed to arsenic |
Q39295658 | Lung sarcoidosis in children: update on disease expression and management. |
Q46246236 | Lung spirometry parameters and diffusion capacity are decreased in patients with Type 2 diabetes |
Q34577008 | Lung volume recruitment in multiple sclerosis |
Q34781472 | Lung volumes and emphysema in smokers with interstitial lung abnormalities |
Q23918142 | Lung-function impairment among US underground coal miners, 2005 to 2009: geographic patterns and association with coal workers' pneumoconiosis |
Q33994495 | MMP12, lung function, and COPD in high-risk populations |
Q37105760 | MUC5B promoter polymorphism and interstitial lung abnormalities |
Q35950483 | Major affective disorders in chronic obstructive pulmonary disease compared with other chronic respiratory diseases |
Q43003334 | Malondialdehyde and superoxide dismutase correlate with FEV(1) in patients with COPD associated with wood smoke exposure and tobacco smoking |
Q24655820 | Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial |
Q92424726 | Management of chronic obstructive pulmonary disease-A position statement of the South African Thoracic Society: 2019 update |
Q47709124 | Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV. |
Q37218032 | Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis |
Q51219913 | Maximal respiratory pressure reference values for Navajo children ages 6-14. |
Q30493982 | Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort |
Q37139766 | Measurement of intraindividual airway tone heterogeneity and its importance in asthma |
Q35174449 | Measurement of lung airways in three dimensions using hyperpolarized helium-3 MRI |
Q47275872 | Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. |
Q24633262 | Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function |
Q33652576 | Metabolic syndrome and associated factors in people with chronic obstructive pulmonary disease |
Q64949123 | Metabolomics Identifies Novel Blood Biomarkers of Pulmonary Function and COPD in the General Population. |
Q36759384 | Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16. |
Q33821168 | Methodology for using long-term accelerometry monitoring to describe daily activity patterns in COPD |
Q36182205 | Methylated Genes in Sputum Among Older Smokers With Asthma. |
Q47655196 | MicroRNA Signature of Cigarette Smoking and Evidence for a Putative Causal Role of MicroRNAs in Smoking-Related Inflammation and Target Organ Damage. |
Q40449041 | Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial. |
Q33769885 | Midlife determinants associated with sedentary behavior in old age. |
Q35184970 | Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study |
Q55292791 | Mobility limitations related to reduced pulmonary function among aging people with chronic obstructive pulmonary disease. |
Q23917608 | Modification of Traffic-related Respiratory Response by Asthma Control in a Population of Car Commuters |
Q37013954 | Mold and Alternaria skin test reactivity and asthma in children in Connecticut |
Q41898716 | Molecular biomarkers for quantitative and discrete COPD phenotypes. |
Q34483166 | Molecular phenotyping of severe asthma using pattern recognition of bronchoalveolar lavage-derived cytokines |
Q23916728 | Mortality among sheet metal workers participating in a respiratory screening program |
Q35462549 | Motivating smokers in the hospital pulmonary function laboratory to quit smoking by use of the lung age concept |
Q40426400 | Mouse Sensitization and Exposure Are Associated with Asthma Severity in Urban Children |
Q36355275 | Mucus distribution model in a lung with cystic fibrosis |
Q28389258 | Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations |
Q33783497 | Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis |
Q56337665 | Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function |
Q33874056 | Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis |
Q41456444 | NHANES III equations enhance early detection and mortality prediction of bronchiolitis obliterans syndrome after hematopoietic SCT. |
Q64135155 | NIOSH's Respiratory Health Division: 50 years of science and service |
Q55648659 | NOX4 expression and distal arteriolar remodeling correlate with pulmonary hypertension in COPD. |
Q57178925 | NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort |
Q35085226 | National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report |
Q37678022 | Native American ancestry, lung function, and COPD in Costa Ricans |
Q36203188 | Negative life events and quality of life in adults with asthma |
Q47562867 | Neighborhood Perceptions and Cumulative Impacts of Low Level Chronic Exposure to Fine Particular Matter (PM2.5) on Cardiopulmonary Health. |
Q36290732 | Neurocognitive function and CNS integrity in adult survivors of childhood hodgkin lymphoma |
Q35683036 | New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. |
Q59799557 | New Spirometry Indices for Detecting Mild Airflow Obstruction |
Q30586397 | New population-based reference values for spinal mobility measures based on the 2009-2010 National Health and Nutrition Examination Survey |
Q44235604 | New predictive equations for spirometric reference values and comparison with Morris equation in a Korean population |
Q51901755 | New reference values for forced spirometry in white adults in Brazil. |
Q35013181 | New stable isotope method to measure protein digestibility and response to pancreatic enzyme intake in cystic fibrosis |
Q51453361 | Newer equations better predict lung age in smokers: a retrospective analysis using a cohort of randomly selected participants. |
Q47249245 | Nitrogen dioxide exposure in school classrooms of inner-city children with asthma |
Q34480370 | Nocturnal asthma and the importance of race/ethnicity and genetic ancestry |
Q89808062 | Non-communicable respiratory disease and air pollution exposure in Malawi: a prospective cohort study |
Q62489007 | Noncommunicable Respiratory Disease and Air Pollution Exposure in Malawi (CAPS). A Cross-Sectional Study |
Q51371168 | Noninvasive assessment of normality of VD/VT in clinical cardiopulmonary exercise testing utilizing incremental cycle ergometry. |
Q38326090 | Noninvasive effects measurements for air pollution human studies: methods, analysis, and implications |
Q35136650 | Noninvasive tests for the diagnostic evaluation of dyspnea among outpatients: the Multi-Ethnic Study of Atherosclerosis lung study |
Q46532292 | Nonparametric spirometry reference values for Hispanic Americans |
Q46132232 | Normal pulmonary gas exchange efficiency and absence of exercise-induced arterial hypoxemia in adults with bronchopulmonary dysplasia. |
Q51835802 | Normal spirometric reference values for Omani adults. |
Q51238874 | Normal spirometry values in healthy elderly: the Rotterdam Study. |
Q35004736 | Normalized T1 magnetic resonance imaging for assessment of regional lung function in adult cystic fibrosis patients--a cross-sectional study |
Q35216434 | Novel equations better predict lung age: a retrospective analysis using two cohorts of participants with medical check-up examinations in Japan |
Q37102014 | Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons |
Q34756865 | ORMDL3 gene is associated with asthma in three ethnically diverse populations |
Q37109180 | Obesity and Functioning Among Individuals with Chronic Obstructive Pulmonary Disease (COPD). |
Q35815875 | Obesity and Pulmonary Function in African Americans |
Q35672863 | Obesity and bronchodilator response in black and Hispanic children and adolescents with asthma |
Q36955909 | Obesity as a susceptibility factor to indoor particulate matter health effects in COPD. |
Q38829727 | Objective Measurement of Adherence to Out-Patient Airway Clearance Therapy by High-Frequency Chest Wall Compression in Cystic Fibrosis. |
Q94571769 | Objective secondhand smoke exposure in chronic obstructive pulmonary disease patients without active smoking: the U.S. National Health and Nutrition Examination Survey (NHANES) 2007-2012 |
Q36977092 | Observations on the physiological interactions between obesity and asthma |
Q23918237 | Obstructive airways disease with air trapping among firefighters exposed to World Trade Center dust |
Q30884867 | Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. |
Q33187560 | Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination |
Q37553292 | Obstructive lung disease in Mexican Americans and non-Hispanic whites: an analysis of diagnosis and survival in the National Health and Nutritional Examination Survey III Follow-up Study |
Q23917611 | Occupation and the prevalence of respiratory health symptoms and conditions: the Atherosclerosis Risk in Communities study |
Q23917606 | Occupation and three-year incidence of respiratory symptoms and lung function decline: the ARIC study |
Q47133826 | Occupation exposed to road-traffic emissions and respiratory health among Congolese transit workers, particularly bus conductors, in Kinshasa: a cross-sectional study |
Q58586097 | Occupational Exposures Influence CT Imaging Characteristics in the SPIROMICS Cohort |
Q64129812 | Occupational exposure and airflow obstruction and self-reported COPD among ever-employed US adults using a COPD-job exposure matrix |
Q38836309 | Occupational exposure and risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis |
Q39241273 | Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults |
Q28392056 | Occupational exposures and the risk of COPD: dusty trades revisited |
Q28391155 | Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease |
Q26154904 | Occupational lung disease risk and exposure to butter-flavoring chemicals after implementation of controls at a microwave popcorn plant |
Q23910516 | Occupational risk factors for COPD phenotypes in the Multi-Ethnic Study of Atherosclerosis (MESA) lung study |
Q23919894 | Occupational toxicant inhalation injury: the World Trade Center (WTC) experience |
Q39899521 | Occupations associated with COPD risk in the large population-based UK Biobank cohort study |
Q36588294 | Office-based spirometry for early detection of obstructive lung disease |
Q23910900 | Official American Thoracic Society technical standards: spirometry in the occupational setting |
Q64282656 | Omega-3 fatty acid intake and prevalent respiratory symptoms among U.S. adults with COPD |
Q50192518 | On ecological fallacy, assessment errors stemming from misguided variable selection, and the effect of aggregation on the outcome of epidemiological study. |
Q45939644 | Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. |
Q40769656 | One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial. |
Q51706617 | Operating lung volumes are affected by exercise mode but not trunk and hip angle during maximal exercise. |
Q33725822 | Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis. |
Q28387875 | Oscillometry complements spirometry in evaluation of subjects following toxic inhalation |
Q55180835 | Osteoporosis Is Associated with Deteriorating Clinical Status in Adults with Cystic Fibrosis. |
Q36602287 | Outcome measures for COPD treatments: a critical evaluation |
Q35801062 | Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease. |
Q35009178 | Outcome reliability in non-ambulatory boys/men with Duchenne muscular dystrophy |
Q51247413 | Oxidative Stress and Genetic Variants of Xenobiotic-Metabolising Enzymes Associated with COPD Development and Severity in Serbian Adults. |
Q46790500 | Oxidative stress and pulmonary function in the general population |
Q35053222 | Oxygen and ventilatory output during several activities of daily living performed by COPD patients stratified according to disease severity |
Q38764253 | PAI-1 gain-of-function genotype, factors increasing PAI-1 levels, and airway obstruction: The GALA II Cohort. |
Q90684991 | Paired CT Measures of Emphysema and Small Airways Disease and Lung Function and Exercise Capacity in Smokers with Radiographic Bronchiectasis |
Q33938384 | Parameters of lung inflammation in asthmatic as compared to healthy children in a contaminated city |
Q35668528 | Paraseptal emphysema: Prevalence and distribution on CT and association with interstitial lung abnormalities |
Q28950569 | Paresthesias among community members exposed to the World Trade Center disaster |
Q36534745 | Pathophysiological Factors in the Relationship between Chronological Age and Calculated Lung Age as Detected in a Screening Setting in Community-Dwelling Subjects |
Q89635456 | Patient and site characteristics associated with pirfenidone and nintedanib use in the United States; an analysis of idiopathic pulmonary fibrosis patients enrolled in the Pulmonary Fibrosis Foundation Patient Registry |
Q90449530 | Pattern of lung function decline in patients with amyotrophic lateral sclerosis: implications for timing of noninvasive ventilation |
Q88104954 | Patterns of Body Composition Relating to Chronic Respiratory Diseases Among Adults in Four Resource-Poor Settings in Peru |
Q37274181 | Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma |
Q35026131 | Peak Expiratory Flow as a Surrogate for Health Related Quality of Life in Chronic Obstructive Pulmonary Disease: A Preliminary Cross Sectional Study |
Q51779679 | Peak expiratory flow in normals: comparison of the mini Wright versus spirometric predicted peak flows. |
Q55313032 | Pectoralis muscle area and mortality in smokers without airflow obstruction. |
Q33896077 | Perceived neighborhood safety and asthma morbidity in the school inner-city asthma study |
Q33921323 | Percent emphysema, airflow obstruction, and impaired left ventricular filling |
Q34151082 | Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences. |
Q33577395 | Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study |
Q57058386 | Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis |
Q25930050 | Performance of maximum inspiratory pressure tests and maximum inspiratory pressure reference equations for 4 race/ethnic groups |
Q34872797 | Performing a lung disability evaluation: how, when, and why? |
Q23912021 | Pericardial fat is associated with impaired lung function and a restrictive lung pattern in adults: The Jackson Heart Study |
Q35958620 | Perinatal hypoxia increases susceptibility to high-altitude polycythemia and attendant pulmonary vascular dysfunction |
Q23912731 | Periodic spirometry in occupational setting: improving quality, accuracy, and precision |
Q37074953 | Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD. |
Q46453243 | Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis |
Q28755147 | Personal and ambient air pollution exposures and lung function decrements in children with asthma |
Q28766354 | Personal and ambient air pollution is associated with increased exhaled nitric oxide in children with asthma |
Q47272851 | Perspectives on the relevance of the circadian time structure to workplace threshold limit values and employee biological monitoring. |
Q52858793 | Pet Groomer's Lung: A novel occupation related hypersensitivity pneumonitis related to pyrethrin exposure in a pet groomer. |
Q43606071 | Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma |
Q46107352 | Pharmacogenetics of asthma controller treatment |
Q37600573 | Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine |
Q89122759 | Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis |
Q51576632 | Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies. |
Q36185922 | Phenotype of normal spirometry in an aging population |
Q38836539 | Phenotypes of Rapid Cystic Fibrosis Lung Disease Progression during Adolescence and Young Adulthood |
Q34619853 | Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene |
Q37466878 | Phosphodiesterase V inhibition reduces airway responsiveness, but does not improve the beneficial effect of deep inspiration |
Q92426863 | Physical Activity in Overlap Syndrome of COPD and Obstructive Sleep Apnea: Relationship With Markers of Systemic Inflammation |
Q40864350 | Physical activity in people with asbestos related pleural disease and dust-related interstitial lung disease: An observational study. |
Q37307535 | Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding. EDEN trial follow-up |
Q45910187 | Physiologic effects of an ambulatory ventilation system in chronic obstructive pulmonary disease. |
Q26830471 | Physiological and management implications of obesity in critical illness |
Q41186278 | Physiological and perceptual responses to incremental exercise testing in healthy men: effect of exercise test modality. |
Q37629575 | Physiological mechanisms of dyspnea during exercise with external thoracic restriction: role of increased neural respiratory drive. |
Q44842534 | Physiological mechanisms of sex differences in exertional dyspnoea: role of neural respiratory motor drive |
Q43441027 | Physiologically interpretable prediction equations for spirometric indexes |
Q35989628 | Physiology of oxygen uptake kinetics: Insights from incremental cardiopulmonary exercise testing in the Study of Health in Pomerania |
Q36070386 | Pilot Feasibility Study of Comprehensive Pulmonary Evaluation Following Lung Radiation Therapy |
Q35077912 | Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD. |
Q47694738 | Plasma Leptin and Reduced FEV1 and FVC in Chronic Spinal Cord Injury. |
Q35046565 | Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. |
Q78600290 | Plasma and red blood cell zinc in cystic fibrosis |
Q35800358 | Plasma antioxidants are associated with impaired lung function and COPD exacerbations in smokers |
Q28389768 | Plasma sphingomyelin and longitudinal change in percent emphysema on CT. The MESA lung study |
Q40216520 | Pleural abnormalities in the Framingham Heart Study: prevalence and CT image features. |
Q92475323 | PneumoLaus: Prévalence de troubles respiratoires fonctionnels dans un échantillon de la population lausannoise |
Q33933207 | Pneumocystis jirovecii colonization is associated with enhanced Th1 inflammatory gene expression in lungs of humans with chronic obstructive pulmonary disease |
Q57955575 | Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD |
Q90414332 | Pneumoproteins are associated with pulmonary function in HIV-infected persons |
Q48263535 | Pneumothorax After Transbronchial Biopsy in Pulmonary Fibrosis: Lessons from the Multicenter COMET Trial. |
Q51494013 | Polymorphic Variants 279R and 668Q Augment Activity of Matrix Metalloproteinase-9 in Breath Condensates of Children with Asthma. |
Q35664965 | Polymorphism in Osteopontin Gene (SPP1) Is Associated with Asthma and Related Phenotypes in a Puerto Rican Population |
Q30419419 | Poor asthma control in obese children may be overestimated because of enhanced perception of dyspnea |
Q36031114 | Population Pharmacokinetics and Pharmacodynamics of GSK961081 (Batefenterol), a Muscarinic Antagonist and β2-Agonist, in Moderate-to-Severe COPD Patients: Substudy of a Randomized Trial |
Q43936195 | Population pharmacokinetics of inhaled umeclidinium and vilanterol in patients with chronic obstructive pulmonary disease |
Q27968997 | Post-9/11/2001 lung function trajectories by sex and race in World Trade Center-exposed New York City emergency medical service workers |
Q48646436 | Potassium kinetics and its relationship with ventilation during repeated bouts of exercise in women. |
Q23917610 | Poultry processing work and respiratory health of Latino men and women in North Carolina |
Q28067387 | Practical Recommendations for Diagnosis and Management of Respiratory Muscle Weakness in Late-Onset Pompe Disease |
Q35425062 | Practical surrogate marker of pulmonary dysanapsis by simple spirometry: an observational case-control study in primary care |
Q37300877 | Pragmatic research and outcomes in asthma and COPD |
Q35451346 | Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study |
Q33811274 | Pre-hematopoietic stem cell transplant lung function and pulmonary complications in children |
Q30433497 | Predicting intermediate phenotypes in asthma using bronchoalveolar lavage-derived cytokines |
Q37220816 | Prediction equations for diffusing capacity (transfer factor) of lung for North Indians |
Q37723204 | Prediction equations for pulmonary function values in healthy children in Mashhad city, North East Iran |
Q39703507 | Prediction equations for pulmonary function values in healthy young Iranians aged 8-18 years |
Q60912870 | Prediction of lung function using handgrip strength in healthy young adults |
Q51064115 | Prediction of pulmonary restriction from forced vital capacity in elderly is similar using GLI and ERS equations. |
Q30481059 | Predictive 5-year survivorship model of cystic fibrosis |
Q34718446 | Predictive equations using regression analysis of pulmonary function for healthy children in Northeast China |
Q46099863 | Predictive models and spatial variations of vital capacity in healthy people from 6 to 84 years old in China based on geographical factors |
Q49521857 | Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes. |
Q92495957 | Predictors of accelerated FEV1 decline in adults with airflow limitation-Findings from the Health2006 cohort |
Q46950827 | Predictors of body mass index in patients with moderate to severe emphysema |
Q34085743 | Predictors of dyspnoea prevalence: results from the BOLD study. |
Q33683010 | Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score |
Q47386354 | Premature birth affects the degree of airway dysanapsis and mechanical ventilatory constraints. |
Q41896586 | Preoperative and Postoperative Pulmonary Function in Elderly Patients with Thoracolumbar Kyphoscoliosis |
Q81238089 | Preoperative gender differences in pulmonary gas exchange in morbidly obese subjects |
Q35906562 | Present and future costs of COPD in Iceland and Norway: results from the BOLD study |
Q37501498 | Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD |
Q44261506 | Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study |
Q35073305 | Prevalence and clinical characteristics associated with pulmonary hypertension in African-Americans |
Q64882969 | Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study. |
Q64109652 | Prevalence and factors associated with asthma among adolescents and adults in Uganda: a general population based survey |
Q28387926 | Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study |
Q42121389 | Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis. |
Q34621075 | Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users. |
Q52591335 | Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. |
Q33794627 | Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care |
Q54975610 | Prevalence of COPD and respiratory symptoms associated with biomass smoke exposure in a suburban area. |
Q28660851 | Prevalence of COPD and tobacco smoking in Tunisia--results from the BOLD study |
Q26343330 | Prevalence of airflow obstruction among ever-employed US adults aged 18-79 years by longest held occupation group: National Health and Nutrition Examination Survey 2007-2008. Erratum |
Q39036540 | Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: The cross-sectional BOLD study |
Q23910517 | Prevalence of airflow obstruction in U.S. adults aged 40-79 years: NHANES data 1988-1994 and 2007-2010 |
Q37103925 | Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study |
Q37392322 | Prevalence of alpha-1 antitrypsin deficiency and allele frequency in patients with COPD in Brazil |
Q37248426 | Prevalence of chronic airflow limitation in Kashmir, North India: results from the BOLD study |
Q57456990 | Prevalence of chronic obstructive pulmonary disease (COPD) among Congolese cement workers exposed to cement dust, in Kongo Central Province |
Q53723034 | Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. |
Q28650105 | Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru |
Q33974119 | Prevalence of chronic obstructive pulmonary disease in kocaeli: an industrialised city in Turkey. |
Q90263181 | Prevalence of chronic respiratory disease in urban and rural Uganda |
Q38681821 | Prevalence of high fractional exhaled nitric oxide among US youth with asthma. |
Q41659539 | Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene |
Q92813158 | Prevalence of smoking and reasons for continuing to smoke: a population-based study |
Q91871933 | Prevalence, Awareness, and Associated Factors of Airflow Obstruction in Russia: The Ural Eye and Medical Study |
Q34448365 | Prevalence, clinical profile, iron status, and subject-specific traits for excessive erythrocytosis in andean adults living permanently at 3,825 meters above sea level |
Q33782278 | Probability of treatment following acute decline in lung function in children with cystic fibrosis is related to baseline pulmonary function |
Q23911738 | Profusion of opacities in simple coal worker's pneumoconiosis is associated with reduced lung function |
Q52660595 | Prognostic Significance of Large Airway Dimensions on Computed Tomography in the General Population: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study. |
Q35816307 | Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study |
Q35598652 | Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma |
Q27023983 | Promotion of lung health: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases |
Q33824058 | Proportional classifications of COPD phenotypes. |
Q37404519 | Prospective evaluation of haemoglobin oxygen saturation at rest and after exercise in paediatric sickle cell disease patients |
Q45037017 | Prospective evaluation of pulmonary function in Parkinson's disease patients with motor fluctuations |
Q63976605 | Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis |
Q47729600 | Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study |
Q48219744 | Proteomic profiling identifies novel circulating markers associated with bronchiectasis in cystic fibrosis. |
Q90308682 | Proximity to major roadways and asthma symptoms in the School Inner-City Asthma Study |
Q88407213 | Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort |
Q40164055 | Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres |
Q35127240 | Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor |
Q28390253 | Pulmonary Disease and Age at Immigration among Hispanics. Results from the Hispanic Community Health Study/Study of Latinos |
Q38715671 | Pulmonary Endpoints in Duchenne Muscular Dystrophy. A Workshop Summary |
Q35747427 | Pulmonary Function After Treatment for Embryonal Brain Tumors on SJMB03 That Included Craniospinal Irradiation |
Q40661649 | Pulmonary Function after Treatment for Childhood Cancer. A Report from the St. Jude Lifetime Cohort Study (SJLIFE). |
Q35053051 | Pulmonary Function in HIV-Infected Recreational Drug Users in the Era of Anti-Retroviral Therapy |
Q36050587 | Pulmonary Gas Exchange and Exercise Capacity in Adults Born Preterm |
Q90309738 | Pulmonary Impairment after Respiratory Viral Infections Is Associated with High Mortality in Allogeneic Hematopoietic Cell Transplant Recipients |
Q50003699 | Pulmonary Impairment and Risk Assessment in a Diacetyl-exposed Population: Microwave Popcorn Workers. |
Q40643362 | Pulmonary Manifestations of the Autoimmune Lymphoproliferative Syndrome. A Retrospective Study of a Unique Patient Cohort. |
Q28390489 | Pulmonary Microvascular Blood Flow in Mild Chronic Obstructive Pulmonary Disease and Emphysema. The MESA COPD Study |
Q37375728 | Pulmonary Predictors of Incident Diabetes in Smokers. |
Q50203307 | Pulmonary Safety and Tolerability of Inhaled Levodopa (CVT-301) Administered to Patients with Parkinson's Disease. |
Q40470023 | Pulmonary abnormalities as a result of exposure to Libby amphibole during childhood and adolescence-The Pre-Adult Latency Study (PALS). |
Q35359596 | Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease. |
Q38794826 | Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study. |
Q36844372 | Pulmonary cysts identified on chest CT: are they part of aging change or of clinical significance? |
Q81932767 | Pulmonary diffusing capacity for nitric oxide during exercise in morbid obesity |
Q34058786 | Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation |
Q34118967 | Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures |
Q34172133 | Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. |
Q38208793 | Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin |
Q23913168 | Pulmonary function after exposure to the World Trade Center collapse in the New York City Fire Department |
Q51427894 | Pulmonary function after hematopoietic stem cell transplantation is significantly better in pediatric recipients following reduced toxicity compared with myeloablative conditioning. |
Q35600875 | Pulmonary function after whole lung irradiation in pediatric patients with solid malignancies. |
Q27968911 | Pulmonary function among Latino thoroughbred horse farmworkers |
Q83050002 | Pulmonary function and emphysema in Williams-Beuren syndrome |
Q23917174 | Pulmonary function and left ventricular mass in African Americans: The Atherosclerosis Risk in Communities (ARIC) study |
Q40121737 | Pulmonary function and respiratory health of rural farmers and artisanal and small scale gold miners in Ghana |
Q34118274 | Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia |
Q37029883 | Pulmonary function and the risk of functional limitation in chronic obstructive pulmonary disease |
Q46084537 | Pulmonary function disparities exist and persist in Hispanic patients with cystic fibrosis: A longitudinal analysis. |
Q35581177 | Pulmonary function in children and young adults with ataxia telangiectasia |
Q39539874 | Pulmonary function in chronic spinal cord injury: a cross-sectional survey of 222 southern California adult outpatients |
Q45146722 | Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry |
Q51681180 | Pulmonary function in primary pulmonary hypertension. |
Q36776338 | Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study |
Q57412897 | Pulmonary function over 2 years in diabetic patients treated with prandial inhaled Technosphere Insulin or usual antidiabetes treatment: a randomized trial |
Q23914158 | Pulmonary function predicting confirmed recovery from lower-respiratory symptoms in World Trade Center-exposed firefighters, 2001 to 2010 |
Q37504119 | Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. |
Q23921730 | Pulmonary function reductions among potentially susceptible subgroups of agricultural workers in Colorado and Nebraska |
Q51913442 | Pulmonary function testing in New Zealand: the use and importance of reference ranges |
Q35648964 | Pulmonary function testing in asthma: nursing applications |
Q41207430 | Pulmonary function tests for diagnosing lung disease |
Q34990785 | Pulmonary function, chronic respiratory symptoms, and health-related quality of life among adults in the United States--National Health and Nutrition Examination Survey 2007-2010 |
Q51714184 | Pulmonary gas exchange efficiency during exercise breathing normoxic and hypoxic gas in adults born very preterm with low diffusion capacity. |
Q36010579 | Pulmonary hypertension before first and second lung transplantation |
Q33957181 | Pulmonary outcome prediction (POP) tools for cystic fibrosis patients. |
Q46213781 | Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation. |
Q49913847 | Pulmonary sarcoidosis with and without extrapulmonary involvement: a cross-sectional and observational study in China. |
Q59329617 | Pulmonary vascular pruning in smokers with bronchiectasis |
Q51718701 | Pulmonary ventilation defects in older never-smokers. |
Q90709889 | Pulse Oximetry Is Insensitive for Detection of Hepatopulmonary Syndrome in Patients Evaluated for Liver Transplantation |
Q27334864 | Quantification of Diaphragm Mechanics in Pompe Disease Using Dynamic 3D MRI |
Q35589651 | Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence |
Q39150563 | Quantitative CT Measures of Bronchiectasis in Smokers |
Q64096940 | Quantitative CT and pulmonary function in children with post-infectious bronchiolitis obliterans |
Q36990683 | Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults |
Q34352783 | Race and association with disease manifestations and mortality in scleroderma: a 20-year experience at the Johns Hopkins Scleroderma Center and review of the literature. |
Q36243512 | Race, ethnicity and lung function: A brief history |
Q40356888 | Racial and ethnic disparities in survival in lung transplant candidates with idiopathic pulmonary fibrosis. |
Q35064411 | Racial differences in CT phenotypes in COPD. |
Q30429456 | Racial differences in biologic predictors of severe asthma: Data from the Severe Asthma Research Program |
Q57024789 | Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease |
Q36482635 | Racial differences in waiting list outcomes in chronic obstructive pulmonary disease. |
Q44345938 | Racial disparities in asthma-related health outcomes in severe or difficult-to-treat asthma |
Q92830670 | Racial/Ethnic-Specific Differences in the Effects of Inhaled Corticosteroid Use on Bronchodilator Response in Patients With Asthma |
Q35011666 | Radiological correlates and clinical implications of the paradoxical lung function response to β₂ agonists: an observational study |
Q37404094 | Randomized forced titration to different doses of technosphere insulin demonstrates reduction in postprandial glucose excursions and hemoglobin A1c in patients with type 2 diabetes |
Q33487035 | Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers |
Q23920248 | Rapid decline in lung function in coal miners: evidence of disease in small airways |
Q42676730 | Rapid decline in lung function in healthy adults predicts incident excess urinary albumin excretion later in life. |
Q53063789 | Rapid progression of pleural disease due to exposure to Libby amphibole: "Not your grandfather's asbestos related disease". |
Q93086556 | Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies |
Q30446141 | Rationale, design and methods for a community-based study of clustering and cumulative effects of chronic disease processes and their effects on ageing: the Busselton healthy ageing study. |
Q32944299 | Raw milk consumption and other early-life farm exposures and adult pulmonary function in the Agricultural Lung Health Study |
Q23923357 | Rayon flock: a new cause of respiratory morbidity in a card processing plant |
Q41402417 | Re-Defining Lower Limit of Normal for FEV1/FEV6, FEV1/FVC, FEV3/FEV6 and FEV3/FVC to Improve Detection of Airway Obstruction |
Q43191821 | Re: Coates AL, Graham BL, McFadden RG, et al. Spirometry in primary care. Can Respir J 2013;20:13-21. |
Q43823573 | Reasons persons with COPD do not walk and relationship with daily step count |
Q47387538 | Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. |
Q57945503 | Recreational exposure to aerosolized brevetoxins during Florida red tide events |
Q30584222 | Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease |
Q23915574 | Redefining spirometry hesitating start criteria based on the ratio of extrapolated volume to timed FEVs |
Q36637858 | Redistribution of inhaled hyperpolarized 3He gas during breath-hold differs by asthma severity |
Q40314978 | Reduced Forced Vital Capacity in an African Population. Prevalence and Risk Factors. |
Q35861925 | Reduced dynamic hyperinflation after LVRS is associated with improved exercise tolerance |
Q64092184 | Reduced forced vital capacity is independently associated with ethnicity, metabolic factors and respiratory symptoms in a Caribbean population: a cross-sectional study |
Q50664371 | Reference Equations for Spirometry in the Canadian Population. |
Q47351173 | Reference Values for Spirometry Derived Using Lambda, Mu, Sigma (LMS) Method in Korean Adults: in Comparison with Previous References. |
Q34984460 | Reference equation for spirometry interpretation for Eastern India. |
Q36298785 | Reference equations for spirometric indices from a sample of the general adult population in Nigeria |
Q36462832 | Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis |
Q24652803 | Reference ranges for spirometry across all ages: a new approach |
Q36239305 | Reference values for spirometry - report from the Obstructive Lung Disease in Northern Sweden studies |
Q39560303 | Reference values for spirometry and their use in test interpretation: A Position Statement from the Australian and New Zealand Society of Respiratory Science |
Q47116227 | Reference values for spirometry in Chinese aged 4-80 years |
Q47562347 | Reference values for spirometry in elderly individuals: a cross-sectional study of different reference equations |
Q30597870 | Reference values for the pulmonary function of Korean adults using the data of Korea National Health and Nutrition Examination Survey IV (2007-2009). |
Q43113475 | Reference values in lung function testing: all for one and one for all? |
Q92085747 | Refinement of metabolite detection in cystic fibrosis sputum reveals heme correlates with lung function decline |
Q37730093 | Refractory ceramic fiber (RCF) toxicity and epidemiology: a review |
Q47315638 | Regional Heterogeneity of Lobar Ventilation in Asthma Using Hyperpolarized Helium-3 MRI. |
Q35586342 | Regional PM2.5 and asthma morbidity in an agricultural community: a panel study |
Q37147207 | Registration-based assessment of regional lung function via volumetric CT images of normal subjects vs. severe asthmatics |
Q46229429 | Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production |
Q40069350 | Relapse after emergency department discharge for acute asthma |
Q36026697 | Relating small airways to asthma control by using impulse oscillometry in children |
Q91126940 | Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma |
Q50054931 | Relationship between Physical Activity and Fatigue in Adults with Cystic Fibrosis. |
Q28396359 | Relationship between daily exposure to biomass fuel smoke and blood pressure in high-altitude Peru |
Q47635345 | Relationship between exercise capacity and glucose tolerance in cystic fibrosis. |
Q39270415 | Relationship between femur neck bone mineral density and prevalent chronic obstructive pulmonary disease (COPD) or COPD mortality in older non-Hispanic white adults from NHANES III. |
Q34315210 | Relationship between lung function and metabolic syndrome |
Q36507666 | Relationship between pulmonary function and degree of spinal deformity, location of apical vertebrae and age among adolescent idiopathic scoliosis patients. |
Q41752437 | Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis |
Q35537826 | Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis |
Q34231911 | Relationship between serum leptin and chronic obstructive pulmonary disease in US adults: results from the third National Health and Nutrition Examination Survey |
Q36795218 | Relationship between ventilatory function and age in master athletes and a sedentary reference population |
Q90245404 | Relationship of Blood Eosinophils with Fractional Exhaled Nitric Oxide and Pulmonary Function Parameters in Chronic Obstructive Pulmonary Disease (COPD) Exacerbation |
Q36223738 | Relationship of Iron Deficiency and Serum Ferritin Levels with Pulmonary Hypertension: The Jackson Heart Study |
Q36471113 | Relationship of obesity with respiratory symptoms and decreased functional capacity in adults without established COPD |
Q41109827 | Relationship of sleep to pulmonary function in mucopolysaccharidosis II. |
Q35493901 | Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort |
Q64092657 | Relative and absolute lung function change in a general population aged 60-102 years |
Q50577514 | Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts. |
Q35886368 | Reliability in reporting asthma history and age at asthma onset |
Q34923982 | Reliability of FEV1/FEV6 to diagnose airflow obstruction compared with FEV1/FVC: the PLATINO longitudinal study |
Q93174482 | Remission of persistent childhood asthma: Early predictors of adult outcomes |
Q47692517 | Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial. |
Q30411000 | Replication and fine mapping of asthma-associated loci in individuals of African ancestry |
Q92599794 | Reply to Townsend: The American Thoracic Society/European Respiratory Society 2019 Spirometry Statement and Occupational Spirometry Testing in the United States |
Q33705377 | Repository corticotropin for Chronic Pulmonary Sarcoidosis |
Q25933024 | Reproducibility and validity of a handheld spirometer |
Q34277666 | Residential proximity to a major roadway is associated with features of asthma control in children. |
Q47867628 | Resistin is a predictor of asthma risk and resistin:adiponectin ratio is a negative predictor of lung function in asthma. |
Q23921460 | Respirator physiological effects under simulated work conditions |
Q29248197 | Respiratory Effects of Indoor Heat and the Interaction with Air Pollution in Chronic Obstructive Pulmonary Disease |
Q95630673 | Respiratory Flows As A Method For Safely Preventing The Coronavirus Transmission (Covid-19) |
Q57161294 | Respiratory Health Status of Workers in a Bottling Factory in Benin City, Nigeria |
Q40084307 | Respiratory Protection Behavior and Respiratory Indices among Poultry House Workers on Small, Family-Owned Farms in North Carolina: A Pilot Project |
Q38811239 | Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort |
Q36945645 | Respiratory Training Improves Blood Pressure Regulation in Individuals With Chronic Spinal Cord Injury |
Q34903298 | Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function |
Q23917736 | Respiratory disease in agricultural workers: mortality and morbidity statistics |
Q92685719 | Respiratory follow-up pre- and post-engineering controls or cessation of added diacetyl at four microwave popcorn facilities |
Q33997252 | Respiratory function in the elderly |
Q36543650 | Respiratory health and indoor air pollution at high elevation |
Q34499582 | Respiratory health before and after the opening of a road traffic tunnel: a planned evaluation. |
Q43299613 | Respiratory health effects and immunological response to Thermoactinomyces among sugar cane workers in Nicaragua |
Q23920581 | Respiratory health effects associated with restoration work in post-Hurricane Katrina New Orleans |
Q23912522 | Respiratory health of automobile workers and exposures to metal-working fluid aerosols: lung spirometry |
Q37171069 | Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis |
Q35404167 | Respiratory impairment and mortality in older persons: a novel spirometric approach |
Q28397453 | Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function |
Q36487529 | Respiratory impairment in older persons: when less means more. |
Q23917256 | Respiratory inflammatory responses among occupants of a water-damaged office building |
Q36579662 | Respiratory knowledge discovery utilising expertise |
Q32944376 | Respiratory morbidity among U.S. coal miners in states outside of central Appalachia |
Q23919882 | Respiratory morbidity in a coffee processing workplace with sentinel obliterative bronchiolitis cases |
Q23914521 | Respiratory morbidity in office workers in a water-damaged building |
Q34266300 | Respiratory motor function in seated and supine positions in individuals with chronic spinal cord injury. |
Q47820595 | Respiratory muscle endurance training reduces the O2 cost of cycling and perceived exertion in obese adolescents. |
Q45746641 | Respiratory muscle function in patients with cystic fibrosis |
Q34013591 | Respiratory symptom, lung function and exhaled carbon monoxide among a sample of traffic workers in Lagos, Nigeria: A pilot survey |
Q23916394 | Respiratory symptoms and lung function abnormalities related to work at a flavouring manufacturing facility |
Q44584456 | Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air. |
Q37267994 | Respiratory symptoms, sleep-disordered breathing and biomarkers in nocturnal gastroesophageal reflux |
Q44236806 | Respiratory system reactance is an independent determinant of asthma control. |
Q37249983 | Response to albuterol MDI delivered through an anti-static chamber during nocturnal bronchospasm |
Q34079666 | Restrictive lung involvement in facioscapulohumeral muscular dystrophy |
Q36973036 | Restrictive pulmonary deficit is associated with inflammation in sub-optimally controlled obese diabetics |
Q35913286 | Retrospective analysis of lung function abnormalities of Bhopal gas tragedy affected population |
Q43995099 | Rhinitis and onset of asthma: a longitudinal population-based study |
Q36629915 | Risk Factors Associated With Quantitative Evidence of Lung Emphysema and Fibrosis in an HIV-Infected Cohort |
Q37022138 | Risk adjustment for health care financing in chronic disease: what are we missing by failing to account for disease severity? |
Q77792181 | Risk assessment for metalworking fluids and respiratory outcomes |
Q33661274 | Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation |
Q36043404 | Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project |
Q34493241 | Risk factors for chest illness in chronic spinal cord injury: a prospective study |
Q30352400 | Risk factors for lung function decline in a large cohort of young cystic fibrosis patients. |
Q34778001 | Risk factors for montelukast treatment failure in step-down therapy for controlled asthma |
Q33861085 | Risk factors for rate of decline in FEV1 in adults with cystic fibrosis. |
Q44238704 | Risk factors for respiratory symptoms in adults: the Busselton Health Study |
Q40387800 | Risk of Digital Vascular Events in Scleroderma Patients Who Have Both Anticentromere and Anti-Interferon-Inducible Protein 16 Antibodies |
Q41381535 | Risk of Frailty in Elderly With COPD: A Population-Based Study |
Q35995606 | Risk of hemoptysis in cystic fibrosis clinical trials: A retrospective cohort study |
Q23916331 | Risks of a lifetime in construction. Part II: chronic occupational diseases |
Q88239776 | Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review |
Q40714987 | Runners maintain locomotor-respiratory coupling following isocapnic voluntary hyperpnea to task failure |
Q91137185 | Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial |
Q36975931 | Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study |
Q34751469 | Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials |
Q24561751 | Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study |
Q34153752 | Salmeterol use and risk of hospitalization among emergency department patients with acute asthma |
Q45214297 | Sampling airway surface liquid: non-volatiles in the exhaled breath condensate |
Q45714454 | Sarcoidosis in children: HRCT findings and correlation with pulmonary function tests |
Q23909493 | Sarcoidosis, asthma, and asthma-like symptoms among occupants of a historically water-damaged office building |
Q64260276 | Saturated Fat Intake Is Associated with Lung Function in Individuals with Airflow Obstruction: Results from NHANES 2007⁻2012 |
Q98162137 | Scalene and sternocleidomastoid activation during normoxic and hypoxic incremental inspiratory loading |
Q36243235 | School Endotoxin Exposure and Asthma Morbidity in Inner-city Children |
Q35541675 | Screening for Chronic Obstructive Pulmonary Disease (COPD) in an Urban HIV Clinic: A Pilot Study |
Q37589149 | Screening for and early detection of chronic obstructive pulmonary disease |
Q24815213 | Screening for asthma in Cantonese-speaking immigrant children |
Q34310180 | Screening for depression in chronic obstructive pulmonary disease |
Q57812471 | Seasonal fluctuation of lung function in cystic fibrosis: A national register-based study in two northern European populations |
Q89093597 | Secondhand smoke exposure and asthma outcomes among African-American and Latino children with asthma |
Q37364408 | Secondhand tobacco smoke in children with asthma: sources of and parental perceptions about exposure in children and parental readiness to change |
Q37730119 | Self-reactive CFTR T cells in humans: implications for gene therapy. |
Q34333563 | Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study |
Q51685755 | Sensitivity of different spirometric tests for detecting airway obstruction in childhood asthma. |
Q23916385 | Serial evaluations at an indium-tin oxide production facility |
Q36389079 | Serum (1→3)-β-D-glucan levels in HIV-infected individuals are associated with immunosuppression, inflammation, and cardiopulmonary function |
Q35270215 | Serum Adiponectin is Associated with Adverse Outcomes of Asthma in Men but Not in Women |
Q41456647 | Serum Interleukin-6 Levels and Pulmonary Function in Ataxia-Telangiectasia |
Q41401443 | Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency |
Q93150096 | Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial |
Q84239757 | Serum procalcitonin is not an early marker of pulmonary exacerbation in children with cystic fibrosis |
Q35929130 | Serum tocopherol levels and vitamin E intake are associated with lung function in the normative aging study |
Q37175220 | Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica |
Q52888069 | Serum white blood cell count and pulmonary function test are negatively associated. |
Q38954423 | Severity of Airflow Obstruction in Chronic Obstructive Pulmonary Disease (COPD): Proposal for a New Classification. |
Q36013675 | Sex differences in severe pulmonary emphysema |
Q36237239 | Sex differences in the intensity and qualitative dimensions of exertional dyspnea in physically active young adults |
Q42579866 | Sex-related differences in respiratory symptoms: results from the BOLD Study. |
Q33736713 | Shared treatment decision making improves adherence and outcomes in poorly controlled asthma |
Q88965426 | Short-Term Particulate Air Pollution Exposure is Associated with Increased Severity of Respiratory and Quality of Life Symptoms in Patients with Fibrotic Sarcoidosis |
Q36652904 | Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis. |
Q37572380 | Short-term exposure to air pollution and lung function in the Framingham Heart Study. |
Q64892329 | Shortened leukocyte telomere length is associated with reduced pulmonary function and greater subsequent decline in function in a sample of World Trade Center responders. |
Q30554706 | Shortness of Breath with Daily Activities questionnaire: validation and responder thresholds in patients with chronic obstructive pulmonary disease |
Q38903266 | Should we treat obesity in COPD? The effects of diet and resistance exercise training |
Q58061937 | Significant Bronchodilator Responsiveness and “Reversibility” in a Population Sample |
Q34547704 | Similar relation of age and height to lung function among Whites, African Americans, and Hispanics |
Q34490634 | Simple office spirometry |
Q36901286 | Simulation of Forced Expiration in a Biophysical Model, With Homogeneous and Clustered Bronchoconstriction |
Q40626542 | Simultaneously elevated exhaled nitric oxide and serum-eosinophil cationic protein relate to recent asthma events in asthmatics in a cross-sectional population-based study |
Q34661935 | Simvastatin for the prevention of exacerbations in moderate-to-severe COPD |
Q45376603 | Sinusoidal high-intensity exercise does not elicit ventilatory limitation in chronic obstructive pulmonary disease |
Q35868743 | Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort |
Q31147166 | Six-minute walk test: reference values and prediction equation in healthy boys aged 5 to 12 years |
Q51912979 | Six-second spirometry for detection of airway obstruction: a population-based study in Austria. |
Q45941316 | Skeletal muscle power and fatigue at the tolerable limit of ramp-incremental exercise in COPD. |
Q37503878 | Skin gene expression correlates of severity of interstitial lung disease in systemic sclerosis |
Q28397048 | Sleep Apnea and Obstructive Airway Disease in Older Men: Outcomes of Sleep Disorders in Older Men Study |
Q47738352 | Sleep Phase Delay in Cystic Fibrosis: A Potential New Manifestation of Cystic Fibrosis Transmembrane Regulator Dysfunction |
Q38928315 | Sleep and pulmonary outcomes for clinical trials of airway plexiform neurofibromas in NF1. |
Q48641123 | Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. |
Q36334507 | Sleep apnea prevalence in chronic kidney disease - association with total body water and symptoms |
Q37140533 | Sleep medicine for surgeons |
Q46642210 | Sleep quality in asthma: results of a large prospective clinical trial |
Q27908626 | Small airway dysfunction and abnormal exercise responses: a study in coal miners |
Q34399973 | Small changes in lung function in runners with marathon-induced interstitial lung edema. |
Q23911736 | Small mine size is associated with lung function abnormality and pneumoconiosis among underground coal miners in Kentucky, Virginia and West Virginia |
Q34787449 | Smoking-associated fibrosis and pulmonary asbestosis. |
Q52081177 | Smooth reference equations for slow vital capacity and flow-volume curve indexes. |
Q39017682 | Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis |
Q37070328 | Socioeconomic gradients in tiotropium use among adults with COPD. |
Q38653345 | Socioeconomic patterning of chronic conditions and behavioral risk factors in rural South Asia: a multi-site cross-sectional study |
Q34637595 | Socioeconomic status and asthma control in African American youth in SAGE II. |
Q51153697 | Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario, Canada. |
Q33943042 | Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis |
Q28385621 | Socioeconomic status, race and COPD health outcomes |
Q37628437 | Soluble Fibre Meal Challenge Reduces Airway Inflammation and Expression of GPR43 and GPR41 in Asthma. |
Q92375514 | Soluble fibre supplementation with and without a probiotic in adults with asthma: A 7-day randomised, double blind, three way cross-over trial |
Q47202121 | Source-specific pollution exposure and associations with pulmonary response in the Atlanta Commuters Exposure Studies |
Q36087017 | Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness |
Q39024368 | Spirometer Replacement and Serial Lung Function Measurements in Population Studies: Results From the SAPALDIA Study |
Q58861132 | Spirometric Function Improves in the Morbidly Obese After 1-Year Post-surgery |
Q92988140 | Spirometric Pulmonary Restriction in Herbicide-Exposed U.S. Vietnam War Veterans |
Q46511246 | Spirometric Reference Values for the 6-s FVC Maneuver * |
Q52558909 | Spirometric Volumes and Breathlessness Across Levels of Airflow Limitation: The COPDGene Study. |
Q23920610 | Spirometric abnormalities associated with chronic bronchitis, asthma, and airway hyperresponsiveness among boilermaker construction workers |
Q39641323 | Spirometric function in children of Mexico City compared to Mexican-American children |
Q33738733 | Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease |
Q50715441 | Spirometric reference equations for Swedish adults. |
Q40302181 | Spirometric reference values for Hopi Native American children ages 4-13 years |
Q39811600 | Spirometric reference values for children and adolescents from Kazakhstan |
Q44507129 | Spirometric reference values for healthy Han children aged 5-15 years in Guangzhou, southern China |
Q51194758 | Spirometric reference values for healthy nonsmoking Saudi adults. |
Q34083273 | Spirometric reference values in Estonian schoolchildren |
Q39531808 | Spirometric reference values in Tunisian children |
Q37408888 | Spirometric variability in smokers: transitions in COPD diagnosis in a five-year longitudinal study. |
Q83612383 | Spirometry |
Q40160447 | Spirometry Reference Equations from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). |
Q37688530 | Spirometry and health status worsen with weight gain in obese smokers but improve in normal-weight smokers |
Q38247045 | Spirometry and regular follow-up do not improve quality of life in children or adolescents with asthma: Cluster randomized controlled trials |
Q35508619 | Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD. |
Q33872320 | Spirometry guidelines influence lung function results in a longitudinal study of young adults |
Q93054932 | Spirometry in Central Asian Lowlanders and Highlanders, a Population Based Study |
Q58131525 | Spirometry in Hospitalized Patients with Acute Exacerbation of COPD Accurately Predicts Post Discharge Airflow Obstruction |
Q86261254 | Spirometry in primary care |
Q23912738 | Spirometry longitudinal data analysis software (SPIROLA) for analysis of spirometry data in workplace prevention or COPD treatment |
Q51840592 | Spirometry reference values for Navajo children ages 6-14 years. |
Q38691608 | Spirometry reference values for population aged 7-80 years in China |
Q37735778 | Spirometry reference values in the Brazilian population |
Q43936590 | Spirometry results (FEV1 and FVC) in young Bantu men from Tanzania vs environmental and family characteristics |
Q38133783 | Spirometry use in children hospitalized with asthma. |
Q34658507 | Spirometry values for detecting a restrictive pattern in occupational health settings |
Q51563504 | Spirometry values in a Greek population: is there an appropriate reference equation? |
Q39429339 | Spirometry, Static Lung Volumes, and Diffusing Capacity |
Q34390999 | Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis. |
Q35581457 | Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores |
Q49954459 | Standardisation of lung function test interpretation: Global Lung Function Initiative. |
Q90712987 | Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement |
Q23919299 | Standardization of spirometry in assessment of responders following man-made disasters: World Trade Center worker and volunteer medical screening program |
Q31003434 | Statistical Modeling of Disease Progression for Chronic Obstructive Pulmonary Disease Using Data from the ECLIPSE Study |
Q89493317 | Statistical Process Control Improves The Feasibility Of Remote Physiological Monitoring In Patients With Chronic Obstructive Pulmonary Disease |
Q38396217 | Statistical models for respiratory disease diagnosis and prognosis |
Q38416014 | Strategies for managing oxygenation in obese patients undergoing laparoscopic surgery. |
Q54954966 | Streamlining cardiopulmonary exercise testing for use as a screening and tracking tool in primary care. |
Q44164358 | Study of active duty military for pulmonary disease related to environmental deployment exposures (STAMPEDE). |
Q34285302 | Studying forced expiratory volume at 1 second over menstrual segments in asthmatic and non-asthmatic women: assessing protocol feasibility |
Q36388421 | Stunting and the Prediction of Lung Volumes Among Tibetan Children and Adolescents at High Altitude |
Q23910004 | Styrene-associated health outcomes at a windblade manufacturing plant |
Q36741308 | Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study |
Q35005632 | Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD. |
Q34065370 | Suboptimal vitamin K status despite supplementation in children and young adults with cystic fibrosis |
Q36032818 | Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency |
Q36060130 | Sulforaphane improves the bronchoprotective response in asthmatics through Nrf2-mediated gene pathways |
Q35936000 | Summarising published results from spirometric surveys of COPD: the problem of inconsistent definitions |
Q36848757 | Survival effect of lung transplantation among patients with cystic fibrosis |
Q50628552 | Switch Now to Modern Spirometry Reference Equations. |
Q36951428 | Symptoms and lung function decline in a middle-aged cohort of males and females in Australia |
Q26826840 | Systematic review with meta-analysis of the epidemiological evidence relating FEV1 decline to lung cancer risk |
Q52570112 | Systemic Inflammation, Immune Activation and Impaired Lung Function among People Living with HIV in Rural Uganda. |
Q28390485 | Systemic inflammation and reduced pulmonary function in chronic spinal cord injury |
Q23909920 | Systemic inflammation associated with World Trade Center dust exposures and airway abnormalities in the local community |
Q33631092 | Systemic inflammation in young adults is associated with abnormal lung function in middle age. |
Q34065448 | Systemic sclerosis and bilateral lung transplantation: a single centre experience |
Q37143961 | T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease. |
Q36165049 | Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension |
Q95780977 | Telephone follow-up after the emergency department visit: experience with acute asthma |
Q73980520 | Testing patients' lungs: spirometry as part of the physical examination |
Q90365272 | The Acute COPD Exacerbation Prediction Tool (ACCEPT): a modelling study |
Q51426953 | The Association Between Bone Mineral Density and Airflow Limitation in a Cohort of Fit Elderly Women. |
Q33917467 | The Asthma Control and Communication Instrument: a clinical tool developed for ethnically diverse populations |
Q89823652 | The Burden of Respiratory Abnormalities Among Workers at Coffee Roasting and Packaging Facilities |
Q36229674 | The Coupling of Peripheral Blood Pressure and Ventilatory Responses during Exercise in Young Adults with Cystic Fibrosis |
Q50091886 | The Dietary Inflammatory Index and Current Wheeze Among Children and Adults in the United States. |
Q47240500 | The Differences in Spirometry Predictive Equations in Classifying Presence and Degree of Lung Function Impairment: Which Suit Fits the Best? |
Q40513699 | The Differential Impact of Emphysema on Respiratory Symptoms and 6-Minute Walk Distance in HIV Infection |
Q36036190 | The Dynamics of Disease Progression in Cystic Fibrosis |
Q38541189 | The Effect of Ancestry and Genetic Variation on Lung Function Predictions: What Is "Normal" Lung Function in Diverse Human Populations? |
Q40005216 | The Effect of Cigarette Smoking on Lung Function in Young Adults with Asthma |
Q40690044 | The Effect of Viral Infection on Exhaled Nitric Oxide in Children with Acute Asthma Exacerbations |
Q36389693 | The European LEMS Registry: Baseline Demographics and Treatment Approaches |
Q41683637 | The Global Lung Function Initiative (GLI) Network: bringing the world's respiratory reference values together |
Q36131162 | The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthma |
Q38992081 | The Influence of 17 Hours of Normobaric Hypoxia on Parallel Adjustments in Exhaled Nitric Oxide and Airway Function in Lowland Healthy Adults |
Q46179312 | The Long-term Oxygen Treatment Trial (LOTT) for Chronic Obstructive Pulmonary Disease: Rationale, Design, and Lessons Learned |
Q24793588 | The Mexican response to high altitudes in the 1890s: the case of a physician and his "magic mountain" |
Q37144539 | The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. |
Q24799294 | The Platino project: methodology of a multicenter prevalence survey of chronic obstructive pulmonary disease in major Latin American cities |
Q36778643 | The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development |
Q40090026 | The Relationship between Dietary Fiber Intake and Lung Function in the National Health and Nutrition Examination Surveys. |
Q34398902 | The SERPINE2 gene is associated with chronic obstructive pulmonary disease |
Q23920402 | The World Trade Center disaster and the health of workers: five-year assessment of a unique medical screening program |
Q24814702 | The World Trade Center residents' respiratory health study: new-onset respiratory symptoms and pulmonary function |
Q58803501 | The accuracy of a handheld "disposable pneumotachograph device" in the spirometric diagnosis of airway obstruction in a Chinese population |
Q37226408 | The accuracy with which the 5 times sit-to-stand test, versus gait speed, can identify poor exercise tolerance in patients with COPD: A cross-sectional study |
Q43468919 | The all-age spirometry reference ranges reflect contemporary Australasian spirometry |
Q34408276 | The association between urinary phthalates and lung function |
Q23913481 | The association of depressive symptoms and pulmonary function in healthy adults |
Q40519463 | The association of lean and fat mass with all-cause mortality in older adults: The Cardiovascular Health Study |
Q38658136 | The association of non-alcoholic fatty liver disease with lung function: A survey design analysis using propensity score |
Q38063275 | The association of overweight and obesity with spirometric values in minority children referred for asthma evaluation. |
Q23915385 | The association of pipe and cigar use with cotinine levels, lung function, and airflow obstruction: a cross-sectional study |
Q35891115 | The association of reduced lung function with blood pressure variability in African Americans: data from the Jackson Heart Study |
Q34290094 | The association of respiratory symptoms and indoor housing conditions among migrant farmworkers in eastern North Carolina |
Q28392241 | The association of systemic microvascular changes with lung function and lung density: a cross-sectional study |
Q27349146 | The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD |
Q36431097 | The burden of asthma in the Chicago community fifteen years after the availability of national asthma guidelines: the design and initial results from the CHIRAH study |
Q35201858 | The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study |
Q35477522 | The clinical features of the overlap between COPD and asthma |
Q37619677 | The clinical impact of non-obstructive chronic bronchitis in current and former smokers |
Q34103360 | The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used |
Q37068152 | The course of persistent airflow limitation in subjects with and without asthma |
Q36645934 | The degree of skin involvement identifies distinct lung disease outcomes and survival in systemic sclerosis. |
Q38367846 | The development of a community-based spirometry service in the Canterbury region of New Zealand: observations on new service delivery. |
Q38217187 | The development of diabetes among Danish cystic fibrosis patients over the last two decades. |
Q37636248 | The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort |
Q35623755 | The effect of applying ethnicity-specific spirometric reference equations to Asian migrant workers in Korea |
Q43559660 | The effect of increased physical activity on pulmonary diffusing capacity in unfit women |
Q37025660 | The effect of omalizumab on ventilation and perfusion in adults with allergic asthma |
Q83172100 | The effects of age on exhaled breath nitric oxide levels |
Q36480468 | The effects of indoor environmental exposures on pediatric asthma: a discrete event simulation model. |
Q33783333 | The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. |
Q44559059 | The effects of smokeless cookstoves on peak expiratory flow rates in rural Honduras |
Q28079363 | The geriatric asthma: pitfalls and challenges |
Q35051364 | The glucocorticoid receptor heterocomplex gene STIP1 is associated with improved lung function in asthmatic subjects treated with inhaled corticosteroids |
Q37351376 | The impact of COPD on health status: findings from the BOLD study |
Q37199660 | The impact of SHS exposure on health status and exacerbations among patients with COPD. |
Q38453923 | The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis |
Q64108340 | The impact of integrated disease management in high-risk COPD patients in primary care |
Q36158231 | The influence of abdominal visceral fat on inflammatory pathways and mortality risk in obstructive lung disease |
Q39908556 | The influence of caregiver's psychosocial status on childhood asthma and obesity |
Q49192254 | The influence of pulmonary vascular pressures on lung diffusing capacity during incremental exercise in healthy aging. |
Q33498530 | The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease |
Q46096589 | The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. |
Q89734537 | The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII |
Q30432832 | The molecular phenotype of severe asthma in children. |
Q39345736 | The multi-ethnic global lung initiative 2012 and Third National Health and Nutrition Examination Survey reference values do not reflect spirometric measurements in Black boys and men from Tanzania |
Q44934998 | The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort |
Q34480202 | The nonallergic asthma of obesity. A matter of distal lung compliance |
Q46774071 | The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction |
Q35173527 | The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease |
Q37395897 | The relation of circulating YKL-40 to levels and decline of lung function in adult life |
Q36212650 | The relationship between pulmonary emphysema and kidney function in smokers |
Q47551741 | The relationship of lung function with ambient temperature |
Q38308864 | The reliability and utility of spirometry performed on people with asthma in community pharmacies |
Q23915620 | The respiratory pyramid: from symptoms to disease in World Trade Center exposed firefighters |
Q51689458 | The risk of osteoporosis in Caucasian men and women with obstructive airways disease. |
Q58543551 | The role of modifiable health-related behaviors in the association between PTSD and respiratory illness |
Q35100318 | The role of physical inactivity in increasing disability among older adults with obstructive airway disease |
Q36351131 | The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease |
Q90285266 | The six-gene expression signature in whole sampled sputum provides clinically feasible inflammatory phenotyping of asthma |
Q36093712 | The use of ethnically specific norms for ventilatory function in African-American and white populations |
Q48452222 | The utility of spirometry in diagnosing pulmonary restriction. |
Q46460401 | The utility of the chest radiograph in diagnosing exacerbations of pulmonary sarcoidosis |
Q30498384 | The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary disease. |
Q23912732 | The value of periodic spirometry for early recognition of long-term excessive lung function decline in individuals |
Q57820642 | Three weeks of respiratory muscle endurance training improve the O cost of walking and exercise tolerance in obese adolescents |
Q33783621 | Three-dimensional imaging of ventilation dynamics in asthmatics using multiecho projection acquisition with constrained reconstruction |
Q37470739 | Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD |
Q28391976 | Time for new reference values for ventilatory lung function |
Q51559655 | Time to First Cigarette, a Proxy of Nicotine Dependence, Increases the Risk of Pulmonary Impairment, Independently of Current and Lifetime Smoking Behavior. |
Q43296661 | Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma |
Q37293223 | Tobacco-stained fingers: a clue for smoking-related disease or harmful alcohol use? A case-control study. |
Q35618488 | Topographic diversity of the respiratory tract mycobiome and alteration in HIV and lung disease |
Q46027761 | Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. |
Q36031045 | Treatment and demographic factors affecting time to next pulmonary exacerbation in cystic fibrosis |
Q40352553 | Treatment burden in patients with at least one class IV or V CFTR mutation |
Q33815570 | Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. |
Q39443839 | Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy |
Q40072877 | Trends in the clinical characteristics of the U.S. cystic fibrosis patient population from 1995 to 2005. |
Q36040678 | Trends in the prevalence of obstructive and restrictive lung function among adults in the United States: findings from the National Health and Nutrition Examination surveys from 1988-1994 to 2007-2010 |
Q42284717 | Trends in the use of routine therapies in cystic fibrosis: 1995-2005. |
Q35153960 | Trends in the use, sociodemographic correlates, and undertreatment of prescription medications for chronic obstructive pulmonary disease among adults with chronic obstructive pulmonary disease in the United States from 1999 to 2010. |
Q23913166 | Trial of prophylactic inhaled steroids to prevent or reduce pulmonary function decline, pulmonary symptoms and airway hyperreactivity in firefighters at the World Trade Center site |
Q43434585 | Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease |
Q91552473 | Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised control |
Q57030986 | Tropheryma whipplei colonization in HIV-infected individuals is not associated with lung function or inflammation |
Q43868778 | Truncal adiposity and lung function in older black women |
Q28390431 | Tuberculosis associates with both airflow obstruction and low lung function: BOLD results |
Q61453236 | Turkish Thoracic Society Consensus Report: Interpretation of Spirometry |
Q36762494 | Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma |
Q36773011 | Twenty-four hour noninvasive ventilation in Duchenne muscular dystrophy: a safe alternative to tracheostomy |
Q43281492 | Two ATS recommended protocols for administration of methacholine are not equal |
Q36841961 | Two-year pulmonary safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 2 diabetes |
Q89566323 | Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc Analysis |
Q51034389 | Understanding socioeconomic and racial differences in adult lung function. |
Q35105649 | Understanding the contribution of native tracheobronchial structure to lung function: CT assessment of airway morphology in never smokers |
Q28388812 | Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study |
Q47633012 | Unemployment in chronic airflow obstruction around the world: results from the BOLD study |
Q36992446 | Unique Abnormalities in Right Ventricular Longitudinal Strain in Systemic Sclerosis Patients |
Q34609902 | Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry |
Q53145864 | Upper thoracic shape in children with pectus excavatum: impact on lung function. |
Q28384655 | Urbanization and Daily Exposure to Biomass Fuel Smoke Both Contribute to Chronic Bronchitis Risk in a Population with Low Prevalence of Daily Tobacco Smoking |
Q36087862 | Urinary albumin-creatinine ratio, estimated glomerular filtration rate, and all-cause mortality among US adults with obstructive lung function |
Q30908524 | Urinary cadmium levels predict lower lung function in current and former smokers: data from the Third National Health and Nutrition Examination Survey |
Q40108006 | Urinary concentrations of pyrethroid metabolites and its association with lung function in a Canadian general population. |
Q40156914 | Use of Exhaled Nitric Oxide as a Biomarker in Diagnosis and Management of Chronic Obstructive Pulmonary Disease |
Q30238814 | Use of FEV1 in cystic fibrosis epidemiologic studies and clinical trials: A statistical perspective for the clinical researcher |
Q35558785 | Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test |
Q36913883 | Use of lambda-mu-sigma-derived Z score for evaluating respiratory impairment in middle-aged persons |
Q42647223 | Use of lung transplantation survival models to refine patient selection in cystic fibrosis. |
Q51640117 | Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match. |
Q35095290 | Using spirometry to rule out restriction in patients with concomitant low forced vital capacity and obstructive pattern |
Q58082888 | Utility of Routine Spirometry Measures for Surveillance of Idiopathic Subglottic Stenosis |
Q46709586 | Utility of impulse oscillometry in young children with asthma. |
Q45794180 | Validating chronic disease ascertainment algorithms for use in the Canadian longitudinal study on aging |
Q33824230 | Validation and development of an immunonephelometric assay for the determination of alpha-1 antitrypsin levels in dried blood spots from patients with COPD. |
Q53642494 | Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure. |
Q62731130 | Validation of Predictive Metabolic Syndrome Biomarkers of World Trade Center Lung Injury |
Q91748098 | Validation of Previous Spirometric Reference Equations and New Equations |
Q89577378 | Validation of Questionnaire-based Case Definitions for Chronic Obstructive Pulmonary Disease |
Q37126872 | Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis |
Q51900069 | Validation of new brazilian predicted values for forced spirometry in caucasians and comparison with predicted values obtained using other reference equations. |
Q55689362 | Validation of the Saint George’s Respiratory Questionnaire in Uganda. |
Q46938827 | Validation of the Sarcoidosis Health Questionnaire in a non-US population |
Q34794305 | Validation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease |
Q52374166 | Validation of the portable Air-Smart Spirometer. |
Q41142121 | Value of preoperative 6-minute walk test for predicting postoperative pulmonary complications |
Q28392852 | Variability in childhood allergy and asthma across ethnicity, language, and residency duration in El Paso, Texas: a cross-sectional study |
Q37144408 | Variability of spirometry in chronic obstructive pulmonary disease: results from two clinical trials |
Q40503203 | Variants in angiopoietin-2 (ANGPT2) contribute to variation in nocturnal oxyhaemoglobin saturation level |
Q33952628 | Variants of asthma and chronic obstructive pulmonary disease genes and lung function decline in aging |
Q34425392 | Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study. |
Q37002006 | Variations in the peak expiratory flow rate with various factors in a population of healthy women of the malwa region of punjab, India |
Q88873802 | Vascular complications in systemic sclerosis: a prospective cohort study |
Q41402198 | Veterans Airflow Obstruction Screening Questionnaire: A Survey to Identify Veterans with Airflow Obstruction |
Q48203091 | Vital capacity and oxygen saturation at rest and after exercise predict hypoxaemia during hypoxic inhalation test in patients with respiratory disease. |
Q35660024 | Vitamin A intake and elevated serum retinol levels in children and young adults with cystic fibrosis |
Q30393837 | Vitamin B(12) status in children with cystic fibrosis and pancreatic insufficiency |
Q34545617 | Vitamin D Deficiency and Reduced Lung Function in Connective Tissue-Associated Interstitial Lung Diseases |
Q39135117 | Vitamin D Insufficiency and Asthma in a US Nationwide Study. |
Q91581928 | Vitamin D Status Modifies the Response to Indoor Particulate Matter in Obese Urban Children with Asthma |
Q33647716 | Vitamin D and pulmonary function in obese asthmatic children |
Q34554796 | Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease |
Q28397350 | Vitamin D deficiency and airflow limitation in the Baltimore Longitudinal Study of Ageing |
Q37679750 | Vitamin D deficiency is associated with pulmonary exacerbations in children with cystic fibrosis |
Q33845615 | Vitamin D levels, lung function, and steroid response in adult asthma |
Q58385305 | Volume Dependence of High-Frequency Respiratory Mechanics in Healthy Adults |
Q38890726 | What Ancestry Can Tell Us About the Genetic Origins of Inter-Ethnic Differences in Asthma Expression |
Q38613628 | What can the CF registry tell us about rare CFTR-mutations? A Belgian study |
Q37253026 | What defines abnormal lung function in older adults with chronic obstructive pulmonary disease? |
Q52672016 | Whole Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma. |
Q100558998 | Whole genome sequence analysis of pulmonary function and COPD in 19,996 multi-ethnic participants |
Q36846440 | Widespread activation of immunity and pro-inflammatory programs in peripheral blood leukocytes of HIV-infected patients with impaired lung gas exchange |
Q41429954 | With Every Upside, There Is a Downside: Chest Radiation and Survivors of Childhood Cancers. |
Q59794403 | Women with COPD by biomass show different serum profile of adipokines, incretins, and peptide hormones than smokers |
Q34402378 | Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. |
Q64136412 | Work Practices and Respiratory Health Status of Appalachian Coal Miners With Progressive Massive Fibrosis |
Q90051347 | Work-related adverse respiratory health outcomes at a machine manufacturing facility with a cluster of bronchiolitis, alveolar ductitis and emphysema (BADE) |
Q23915948 | Work-related spirometric restriction in flavoring manufacturing workers |
Q23912730 | Worksite wellness program for respiratory disease prevention in heavy-construction workers |
Q23913008 | World Trade Center "sarcoid-like" granulomatous pulmonary disease in New York City fire department rescue workers |
Q36110451 | Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study |
Q92564084 | X-linked myotubular myopathy: A prospective international natural history study |
Q37976117 | Year in review 2011: acute lung injury, interstitial lung diseases, physiology, sleep and lung cancer |
Q33918035 | Year-to-year changes in lung function in individuals with cystic fibrosis. |
Q36301011 | Yoga as a Therapy for Adolescents and Young Adults With Cystic Fibrosis: A Pilot Study |
Q80197031 | [Are quality and the extensive use of spirometry compatible?] |
Q79702237 | [Can one use a standard value of the ratio FEV1/FVC as the sole diagnostic criterion for bronchial obstruction?] |
Q54119030 | [Factors influencing pulmonary function in Tunisian women aged 45 years and more] |
Q79761508 | [Physiological factors influencing pulmonary capillary volume and membrane diffusion] |
Q80618967 | [Pulmonary function in Portuguese firefighters] |
Q54115942 | [Spirometric reference equations for Algerians aged 19 to 73 years]. |
Q37706994 | β-2 adrenergic receptor gene methylation is associated with decreased asthma severity in inner-city schoolchildren: asthma and rhinitis. |
Q90447543 | <Editors' Choice> Renewed Japanese spirometric reference variables and risk stratification for postoperative outcomes in COPD patients with resected lung cancer |
Q28397555 | Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obs |
Search more.